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Abstract
Mathematical modeling has been proven to be an extremely useful tool in describing natural
phenomena. It allows one to address questions and test hypotheses that may be unfeasible
or unethical to study in reality. This work seeks to use mathematical models to describe and
study two phenomena, one relating to physiology and the other to the spread of infectious
diseases.
The first modeling study explores the physiological control mechanisms governing heart
rate variability. Correlation between loss of heart rate variability and physiological states
of stress has been well documented in clinical practice and experimental studies, however,
this correlation has not been fully linked to underlying physiological mechanisms. This
study combines two previous mathematical models of neuroendocrine control of heart rate
and circulation to explain the source of heart rate variability in a resting, healthy state.
Respiration is also incorporated into the system of ordinary differential equations as a
disturbance to the system to characterize the role of respiration in heart rate variability.
The second modeling study investigates the contribution of environmental pathways to
Clostridioides difficile transmission in a healthcare setting. C. diff is the leading cause of
nosocomial, infectious diarrhea in United States hospitals and is contracted after antibiotic
use. Colonized patients shed spores that survive for long periods of time on surfaces outside
the host. This study adds environmental reservoirs to a previous mathematical model and
focuses on the contribution of high-touch and low-touch frequency fomites to the transmission
dynamics of the bacteria within a hospital. Due to a small hospital size, patient and pathogen
populations are simulated stochastically and compared with the average population behavior
described by a system of ordinary differential equations.
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A Model to Explore Control
Mechanisms of Heart Rate Variability
1.1 Introduction
Many physiological phenomena have been correlated to specific states of health. However,
potential mechanisms underlying these phenomena may be difficult to study without invasive
procedures. Mathematical models provide a framework to investigate complex physiological
mechanisms driving phenomena, study dynamics of varying states of health, and design
and evaluate efficacy of treatments and therapies. The aim of this study is to formulate a
mathematical model to explore the physiological control mechanisms governing heart rate
variability.
Heart rate variability (abbreviated HRV) is defined as the variation in the duration of RR
intervals on an electrocardiogram (ECG). Correlation between loss of HRV and physiological
states of stress, such as heart disease, diabetes, depression, and obesity, has been well
documented in clinical practice and experimental studies since the 1960s, and is quickly
becoming a noninvasive, diagnostic metric of health. Previous studies of HRV focused on
the statistical analysis of patient time series data. However, this correlation has not been
fully linked to underlying physiological mechanisms.
This study combines two previous mathematical models to explain the source of HRV
in a resting, healthy state. The first previous model describes neuroendocrine control of
heart rate through the Baroreflex Mechanism and Respiratory Sinus Arrhythmia (RSA). The
second previous model describes circulation via fundamental physics principles. Respiration
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is incorporated into the system of ordinary differential equations (ODEs), via respiration-
derived thoracic pressure, as a disturbance to the homeostatic system to characterize the
role of respiration in heart rate variability.
The effect of several parameters on model dynamics, the mean of heart rate, and the
variance of the RR intervals of heart rate was explored. The parameters explored included
parameters whose values were not available in literature, could not be calculated from patient
data, and appear to have a significant effect on model dynamics. Results show that there
appears to be a trade-off occurring for most parameters associated with the Baroreflex
Mechanism. HRV is higher in scenarios that do not produce extreme heart rate and blood
pressure values. For the parameters associated with RSA, a direct correlation between the
parameter values and HRV indicates that RSA contributes to higher HRV.
This project is joint work with Dr. Mette Olufsen of North Carolina State University,
her student Mr. Ben Randall, and Dr. Judy Day of the University of Tennessee, Knoxville.
1.2 Background
1.2.1 Heart Rate Variability
HRV is defined as the variation in the time interval between heartbeats, specifically the
variation in the duration of RR intervals on an ECG signal [45]. As explained in [2],
an ECG machine detects the the electrical activity of the heart and produces a graphical
representation of the signal, measured in millivolts (mV). The basic pattern of a heart beat
seen on an ECG signal is made up of three parts: a P wave, a QRS wave complex, and
a T wave. The sinoatrial node (SA node), located at the top of the right atrium of the
heart, is the pacemaker of the heart and spontaneously produces an electrical impulse that
travels through the atria to the ventricles, causing the heart to contract and pump blood.
The P wave represents the depolarization of the atria, the QRS wave complex represents the
depolarization of the ventricles, and the T wave represents the repolarization of the ventricles.
Repolarization of the atria is obscured by the QRS wave complex. The R wave represents
the depolarization of the main mass of the ventricles, when the heart pumps out most of
the blood, and is therefore the largest wave on an ECG signal. The RR interval is the time
interval between R waves. Figure 1 shows the PQRST pattern on an ECG signal. Variation
in the RR interval changes the heart rate, measured in beats per minute (bpm), over time.
Figures 2 and 3 show two example ECG signals and corresponding heart rate signals. Heart
rate at a particular time is typically calculated from an ECG signal by dividing 60 by the
duration between two identical points of consecutive PQRST patterns, such as the duration
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of the RR interval. In Figure 2 there are five heart beats (PQRST patterns) in six seconds
on the ECG signal, resulting in an average heart rate of 50 bpm. The variance in the RR
intervals is 0.0167 square seconds. The heart rate at time 1.28 seconds, at the end of the first
RR interval, is 60/1.28 = 46.875 bpm. The heart rate at time 2.36 seconds, at the end of the
second RR interval, is 60/1.08 = 55.556 bpm. The heart rate at the end of the remaining
RR intervals is similarly calculated, resulting in the heart rate signal of bpm over time. In
Figure 3 there are nine heart beats in six seconds on the ECG signal, resulting in an average
heart rate of 90 bpm. The variance in the RR intervals is 0.0006 square seconds. As RR
intervals approach constant duration, and HRV decreases, the heart rate signal approaches
a horizontal line. Figure 3 has lower HRV than Figure 2, using variance in the RR intervals
as a metric for HRV.
Correlation between loss of HRV and physiological states of stress (exercise, disease, etc.)
has been well documented in clinical practice and experimental studies [45]. The first study
acknowledging the clinical importance of HRV found that changes in interbeat intervals
preceded fetal distress, well before changes in pulse [38]. An analysis by [49] observed a
decrease in HRV before clinical signs of neonatal sepsis. A study by [65] used HRV analysis
to predict neonatal sepsis before clinical signs. The first investigation to link a decrease in
HRV with death after a heart attack was by [94]. Studies by [46, 48, 96] also linked reduced
HRV with death after a heart attack. Analyses by [14, 71, 72] linked reduced HRV with
congestive heart failure. A study by [86] observed that decreased HRV was associated with
cardiovascular disease and all cause mortality. An investigation by [60] found that HRV was
the single most important predictor of serious ventricular arrhythmias or sudden death. In
[34], hypertension was linked to reduced HRV. In [13], it was observed that decreased HRV
was correlated with depression and death after a heart attack. Studies by [28, 31] found
correlation between depression, anxiety, and panic disorders and reduced HRV. Further
analyses by [88, 83, 7, 43] have associated low HRV with age, hyperglycemia and diabetes,
insomnia, and obesity, respectively. Also, [43] observed an increase in HRV with weight loss.
A study by [20] observed high HRV in physically active people. Even though there have
been numerous studies since the 1960s linking low HRV with physiological states of stress,
this correlation has not been fully linked to underlying physiological mechanisms.
1.2.2 Neuroendocrine System and Circulation
According to [33], the nervous system is comprised of the central nervous system, which
contains the brain and spinal cord, and the peripheral nervous system, which contain all
neurons outside the brain and spinal cord. The peripheral nervous system senses changes in
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the environment (external or internal to the body) and sends afferent signals to the central
nervous system. The central nervous system decides the appropriate response and sends
efferent signals back to the peripheral nervous system to execute the response. The peripheral
nervous system is comprised of the somatic nervous system, which controls voluntary actions
of the body, and the autonomic nervous system, which controls involuntary actions of the
body. The autonomic nervous system is comprised of the parasympathetic nervous system
(PSNS), which controls “rest-and-digest” responses, and the sympathetic nervous system
(SNS), which controls “fight-or-flight” responses. The neuroendocrine system stimulates or
inhibits the PSNS and SNS to modulate the release of hormones to maintain homeostasis.
Neuroendocrine hormones are released into the blood by neurons and influence the function
of cells at other locations in the body.
The Baroreflex Mechanism senses changes in blood pressure and adjusts heart rate
accordingly. When blood pressure changes, baroreceptors (mechanoreceptor sensory
neurons) located in the carotid sinuses stretch and experience wall strain. The baroreceptors
then change their afferent signaling pattern to the cardiac center of the medulla. The medulla
then produces an efferent response through the PSNS and SNS. The PSNS response includes
the release of the hormone acetylcholine to the SA node, which decreases heart rate. The
PSNS response acts as a brake pedal on heart rate and cannot increase heart rate. The SNS
response includes the release of the hormone nor-epinephrine to the SA node, which increases
heart rate. The SNS response acts as a gas pedal on heart rate and cannot decrease heart
rate. When blood pressure increases, the PSNS response is stimulated with a concurrent
inhibition of the SNS response, and heart rate decreases. When blood pressure decreases,
the SNS response is stimulated with a concurrent inhibition of the PSNS response, and heart
rate increases. Breathing causes pressure inside the thoracic cavity to change, changing the
pressure on the aortic arch, where more baroreceptors are located. The Baroreflex Mechanism
senses this change in pressure and adjusts heart rate through the PSNS and SNS response.
Since the PSNS response acts directly on the SA node via the vagus nerve, the PSNS
response is almost instantaneous. Since the SNS response must go through the sympathetic
ganglia chain parallel to the spinal column to get to the SA node, the SNS response is
delayed by about three seconds. (This delay is not considered in this study.) The SA node
spontaneously produces electrical impulses, causing an intrinsic heart rate of about 100 bpm.
At rest, the PSNS is more active (operating at around an 80% activation level) than the
SNS (operating around a 20% activation level) and dampens heart rate to 60-80 bpm. Low
HRV reflects an imbalance of increased SNS activity and decreased PSNS activity.
RSA is the observed phenomenon of heart rate increasing slightly during inhalation and
decreasing slightly during exhalation. Involuntary breathing is determined by the brain when
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chemoreceptor neurons detect changes in the pH level of blood from changes in carbon dioxide
content. Specifically the respiratory center in the medulla stimulate the SNS (and inhibits
the PSNS) to cause the diaphragm and other chest muscles to contract, which increases
the volume, and thus decreases the pressure, in the thoracic cavity, forcing air to rush into
the lungs and an inhalation to occur. Exhalation does not need to be stimulated since the
muscles will elastically recoil, decreasing volume and increasing pressure, forcing air to rush
out. This SNS signal is not transmitted to the SA node, and therefore has no effect on heart
rate. However, there are transient affects on the SA node from the PSNS response due to
proximity of the respiration and heart rate control centers of the medulla that causes an
increase in heart rate.
Circulation functions to service the needs of body tissues, especially the delivery of
oxygen. Blood flow is driven through circulation by the pump that is the heart. During
diastole, the heart is relaxed and refills with blood. During systole, the ventricles contract
to pump blood out of the heart. Blood flows through two loops of circulation: systemic
circulation takes blood between the heart and the body to deliver oxygen to the body tissues
and pulmonary circulation takes blood between the heart and the lungs to pick up oxygen.
Circulation is illustrated in Figure 4.
1.3 Previous Mathematical Models
1.3.1 Li et al. (2014)
Previous studies of HRV focused on the statistical analysis of the correlation between bodily
stress and the loss of HRV in patient time series data. Li et al. [57] was one of the first
studies to attempt to explain the physiological mechanisms behind this correlation through
mathematical modeling. They modified a model from the text [39] that describes circulation
via fundamental physics principles and combined the model with exercise data from healthy
subjects to explain the loss of HRV as exercise workload increased. The model described a
healthy system at homeostasis. The workload signal was inputed and viewed as a disturbance
to the system to analyze how the system responds to changes in workload to maintain
homeostasis. Specifically, the control system was penalized for deviating from homeostasis.
Li et al. forced an exaggerated heart rate signal through alternating workloads around a
low, medium, and high level. They observed that during exercise, muscle tissues need extra
oxygen to maintain the workload. Thus, heart rate and arterial blood pressure increases
to allow more oxygen to be delivered. However, heart rate and arterial blood pressure
can only increase so much before becoming dangerous. At this point, a trade-off in the
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penalizing weights is made meeting between tissue oxygen demand and increasing heart rate
and blood pressure. The model was able to capture the high frequency oscillations seen in
the exaggerated heart rate signal but was unable to capture the low frequency oscillations.
They suggested that respiration may be the missing component of their model.
1.3.2 Randall et al. (2019)
The Valsalva maneuver is a clinical test that assesses the response of the PSNS and SNS
in response to changes in blood pressure. During the Valsalva maneuver, a patient forcibly
exhales against an external resistance, forcing an exaggerated drop in blood pressure and
heart rate. Randall et al. [75] formulated a model of the neuroendocrine response to the
Valsalva maneuver that takes inputs of blood pressure and respiration and produces outputs
of baroreceptor strain, PSNS and SNS tone, and heart rate. The focus of their study was
to use their model to predict PSNS and SNS dysfunction, not HRV. However, this study
was novel in their incorporation of respiration in their model. Describing the mechanics of
breathing and gas exchange alongside circulation would make for a very complex model.
Instead, Randall et al. derived a thoracic pressure signal synced with respiration and added
the role of thoracic pressure in the Baroreflex Mechanism. They also included a description
of RSA as a function of thoracic pressure.
This thesis seeks to use Randall et al.’s mathematical description of neuroendocrine
control of heart rate, incorporating respiration, to explore physiological control mechanisms
governing HRV. Li et al.’s model, excluding the exercise components, is used to make Randall
et al.’s model closed loop, i.e., describe blood pressure as a function of heart rate. Also, this
study does not seek to explain the loss of HRV due to a stress or to predict non-homeostatic
behavior through exaggerated data. Instead, this study aims to explain the origin of HRV
in a healthy, resting state.
1.4 Data
The model formulated to explore physiological control mechanisms governing HRV describes
a system in homeostasis. Data from a healthy, resting person is used to determine some
parameter values and initial conditions, and is compared to the model output. The
respiration signal from the data is inputed and viewed as a disturbance to the system, through
respiration-derived thoracic pressure, to analyze how the system responds to changes in
respiration to maintain homeostasis. The data consists of five minutes of time series signals,
taken at 1,000 Hz for ECG (mV) and blood pressure, measured in millimeters of mercury
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(mmHg), for the control patients of Randall et al. [75] before the Valsalva maneuver occurs
and stored in LabChart [1], data analysis software for biological signals. Heart rate (bpm)
is computed in LabChart from the RR intervals on the ECG signal. The data also contains
the age of the control patient.
The respiration signal (R) is determined from the ECG signal in MATLAB [62], a
numerical computing environment and proprietary programming language, using a protocol
written by Ben Randall from Randall et al. [75] that combined suggestions from [67, 74, 92].
As a patient inhales, the chest expands, causing the electrodes of the ECG-lead to move
farther away from the heart. As a patient exhales, the electrodes move closer to the heart.
Thus the amplitude of the QRS portion of the ECG signal indicates the depth of breathing
and a mechanical respiration signal can be derived from the interpolation of the amplitudes of
the QRS wave complexes of the ECG signal. The P and T waves are filtered out from the QRS
wave complexes to emphasize the Q and R points, the local optima, i.e., the Q and R points,
are determined, and the amplitude between each R and Q point is interpolated through
using PCHIP interpolation, a built-in MATLAB function that preserves monotonicity and
local extrema.
Thoracic pressure (Pth) is determined from the respiration signal since the pressure inside
the thoracic cavity changes with breathing. According to the text [33], average thoracic
pressure is -4 mmHg, compared to atmospheric pressure, and is sub-atmospheric (negative)
to maintain expansion of the lungs. During inhalation, pressure drops to around -6 mmHg
due to increased volume in the thoracic cavity. During exhalation, pressure rises to around
-3.5 mmHg due to decreased volume in the thoracic cavity. Also, during inhalation, the QR
amplitude on the ECG is smallest since the heart is closer to the ECG-lead, and during
exhalation, the QR amplitude is largest since the heart is farther away from the ECG-lead.
Thus the respiration signal (QR amplitudes in mV) can be scaled to determine the thoracic
pressure (in mmHg). To scale the respiration signal, the line through the points (t1, Rmin)
and (t2, Rmax) is mapped to the line through the points (t1, 6) and (t2, 3.5), where t1 and t2
are arbitrary time points, Rmin and Rmax are the means of all local minimums and maximums
of the respiration signal, respectively, and 3.5 and 6 are the minimum and maximum thoracic
pressures (which are treated as positive here because the thoracic pressure will be subtracted
in the model input). The linear mapping must satisfy Equations (1.1) and (1.2). Solving
Equations (1.1) and (1.2) for m and b gives Equations (1.3) and (1.4), and the thoracic
pressure due to respiration in Equation (1.5).
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6 = m ∗Rmin + b (1.1)
3.5 = m ∗Rmax + b (1.2)
=⇒ m = − 6− 3.5
Rmax −Rmin
(1.3)
b = 3.5−m ∗Rmax (1.4)
Pth = m ∗R + b (1.5)
where
Pth = thoracic pressure signal [mmHg]
R = respiration signal [mV ]
Rmin = mean of local mins of R [mV ]
Rmax = mean of local maxs of R [mV ]
m = ratio of Pth amplitude to mean R amplitude [mmHg ·mV −1]
b = vertical shift [mmHg]
Mean arterial systemic blood pressure (MAP ) is used to determine some parameter
values and initial conditions for the model and is derived from the blood pressure signal.
The blood pressure data is measured in the finger and is part of arterial systemic circulation.
The blood pressure signal consists of systolic (SBP ) and diastolic (DBP ) blood pressure.
Since the model does not describe pulsatile blood flow, MAP data is needed to describe
overall blood flow. MAP is defined in Equation (1.6) by [9].
MAP =




MAP = mean arterial blood pressure [mmHg]
SBP = systolic blood pressure [mmHg]
DBP = diastolic blood pressure [mmHg]
The data does not include venous systemic, arterial pulmonary, or venous systemic blood
pressure. However, according to [33], average venous systemic blood pressure is 5-8 mmHg,
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average arterial pulmonary blood pressure is 8-20 mmHg, and average venous pulmonary
blood pressure is 8 mmHg.
ECG, respiration, thoracic pressure, blood pressure, and heart rate data for one patient
are shown in Figure 5.
1.5 Model Formulation
1.5.1 Description of HRV Model
This work aims to gain a better understanding of the physiological mechanisms governing
HRV by incorporating respiration into a combination of two previous mathematical models
that describes a healthy, resting system in homeostasis. Respiration is inputed and viewed as
a disturbance to the system, through respiration-derived thoracic pressure, to analyze how
the system responds to changes in respiration to maintain homeostasis. The first previous
model used is from Randall et al. [75] and describes neuroendocrine control of heart rate
through the Baroreflex Mechanism and RSA. The second previous model used is from the
text [39], used in Li et al. [57], and describes circulation via fundamental physics principles.
Model variables are summarized in Table 1, auxiliary variables are summarized in Table 2,
and a schematic of the model is given in Figure 6.
Baroreflex Mechanism
The Baroreflex Mechanism adjusts heart rate based on changes in pressure to maintain
homeostasis. Baroreceptors are embedded in the interior walls of the carotid sinuses and
aortic arch, and experience pressure both inside and outside the arteries. Since the carotid
sinuses are located in the neck, carotid baroreceptors only experience arterial systemic blood
pressure from inside the artery. Since the aortic arch extends out of the left side of the heart,
aortic baroreceptors experience arterial systemic blood pressure from inside the artery and
thoracic pressure from outside the artery. Thus, the pressure sensed by carotid baroreceptors
(Pc) is defined as the arterial systemic blood pressure (Pas), Equation (1.7), and the pressure
sensed by aortic baroreceptors (Pa) is defined as the difference between the arterial systemic
blood pressure and the thoracic pressure, Equation (1.8).
Pc = Pas (1.7)
Pa = Pas − Pth (1.8)
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where
Pc = pressure on carotid baroreceptors [mmHg]
Pa = pressure on aortic baroreceptors [mmHg]
Pas = blood pressure of arterial systemic circulation [mmHg]
Pth = thoracic pressure signal [mmHg]
Provided Pas > Pth, Pc and Pa will be positive since Pas is positive for all time. Since Pas
is considered low at 70 mmHg and Pth ranges from 3.5 to 6 mmHg on average, this is a
reasonable assumption.
When blood pressure changes, large arteries, such as the carotid arteries and aorta,
distend and experience wall strain. According to [5], the relationship between arterial cross-
sectional area (A) and blood pressure (P ) is given by Equation (1.9). Equation (1.9) is a type
III functional response [37] where arterial cross-sectional area increases with blood pressure
and area saturates at low and high pressures since arteries can only physically distend so
far. Randall et al. [75] used a type II functional response where area saturates only at
high pressures. Figure 7 illustrates the area-pressure relationship for different values of q,
which determines how quickly cross-sectional area increases with blood pressure. Strain (ε)
describes deformation of a material in terms of relative displacement. Arterial wall strain
(εw), described by Equation (1.10), is the ratio of the change in the radius of an artery when
stressed to the radius of the stressed artery. Equations (1.11)-(1.13) use Equations (1.9) and
(1.10) to model arterial wall strain as a function of blood pressure.
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A(P ) = A0 + (AM − A0)
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A = arterial cross-sectional area [cm2]
AM = maximally stressed arterial cross-sectional area [cm
2]
A0 = unstressed arterial cross-sectional area [cm
2]
P = blood pressure of artery [mmHg]
P ∗ = average blood pressure of artery [mmHg]
q = sigmoid steepness constant for arterial wall strain [dimensionless]
εw = arterial wall strain [dimensionless]
r = stressed arterial radius [cm]
r0 = unstressed arterial radius [cm]
Thus, the relationship between pressure and arterial wall strain for the carotid arteries and

























εwc = arterial wall strain of carotid sinuses [dimensionless]
εwa = arterial wall strain of aortic arch [dimensionless]
Pc = pressure on carotid baroreceptors [mmHg]
Pa = pressure on aortic baroreceptors [mmHg]
A = maximally stressed to unstressed arterial cross-sectional area ratio [dimensionless]
qw = sigmoid steepness constant for wall strain [dimensionless]
sw = sigmoid shift constant for arterial wall strain [mmHg]
Since the maximally stressed cross-sectional area of an artery will be greater than the
unstressed cross-sectional area, A > 1. Thus, since Pc, Pa, and sw are positive, the
quantity under the square root in Equations (1.14) and (1.15) will be less than 1. Therefore,
εwc, εwa ∈ (0, 1).
Since baroreceptors are embedded in the walls of arteries, they will also experience strain
as arteries distend due to changes in blood pressure. Following [59], it is assumed that
baroreceptors behave viscoelastically and the surrounding arterial wall behaves elastically.
Elastic materials immediately return to their original state after experiencing strain. Viscous
materials return to their original state over time after experiencing strain. Viscoelastic
materials display both elastic and viscous characteristics. A simple model describing a
viscoelastic material is the Voigt body, a damper (viscous) and spring (elastic) in parallel
that exhibits the rate of stress relaxation in response to strain. A spring, representing
the surrounding arterial wall, and a Voigt body, representing the baroreceptors, in series
adequately describes baroreceptor strain (εb) as an artery experiences wall strain. Equation
(1.16) describes the spring and Voigt body model for baroreceptor strain as a function of




b + µ1εb = µ0εw (1.16)
where
εb = strain of baroreceptors [dimensionless]
εw = arterial wall strain [dimensionless]
µ0 = proportionality constant of spring [dimensionless]
µ1 = proportionality constant of spring in Voigt body [dimensionless]
η1 = proportionality constant of damper in Voigt body [sec]
Letting Kb = µ0/µ1 and τb = η1/µ1, and solving Equation (1.16) for ε
′
b gives Equations (1.17)










εbc = strain of carotid baroreceptors [dimensionless]
εba = strain of aortic baroreceptors [dimensionless]
εwc = arterial wall strain of carotid sinuses [dimensionless]
εwa = arterial wall strain of aortic arch [dimensionless]
Kb = gain constant for strain of baroreceptors [dimensionless]
τb = time constant for strain of baroreceptors [sec]
Afferent signaling of baroreceptors to the medulla varies in response to changes in strain.
According to the text [33], as an artery wall distends due to increased blood pressure, and
baroreceptors experience more strain, sodium ion channels in the membrane of baroreceptors
open. An influx of positively charged sodium ions causes the baroreceptors to fire action
potentials to the medulla. As an artery wall contracts due to decreased blood pressure, and
baroreceptors experience less strain, sodium ion channels in the membrane of baroreceptors
close. With fewer positively charged ions, the threshold is not met to fire an action potential
to the medulla. Some sodium ion channels are always open, so baroreceptors are constantly
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sending strain information to the medulla, but will fire action potentials at a faster rate when
under strain. Little is known about how information from various baroreceptor locations is
integrated in the medulla. This model, therefore, does not model the individual firing of
baroreceptors. Instead the neural integration (n) of baroreceptor signals is assumed to be a
linear combination of the signals from the carotid sinuses and the aortic arch, as described
by Equation (1.19). The afferent signal from the baroreceptors is the strain experienced in
distention relative to the strain experienced not in distention, the difference between the
arterial wall strain and the baroreceptor strain.
n = B(εwc − εbc) + (1−B)(εwa − εba) (1.19)
where
n = afferent signal of baroreceptors [sec−1]
εwc = arterial wall strain of carotid sinues [dimensionless]
εwa = arterial wall strain of aortic arch [dimensionless]
εbc = strain of carotid baroreceptors [dimensionless]
εba = strain of aortic baroreceptors [dimensionless]
B = linear combination constant for afferent signal of baroreceptors [sec−1]
To show that n > 0, two cases are considered for Equations (1.17) and (1.18). Parameters
τb and Kb are positive, B ∈ [0, 1], and εwc, εwa ∈ (0, 1).
Case 1: ε′bi ≥ 0 for i = {c, a}
ε′bi ≥ 0 =⇒ Kbεwi = τbε′bi + εbi ≥ εbi




=⇒ εwi − εbi > 0
=⇒ n = B(εwc − εbc) + (1−B)(εwa − εba) > 0
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Case 2: ε′bi < 0 for i = {c, a}
ε′bi < 0 =⇒ Kbεwi = τbε′bi + εbi < εbi
=⇒ n = B(εwc − εbc) + (1−B)(εwa − εba)
> B(εwc −Kbεwc) + (1−B)(εwa −Kbεwa)
= B(1−Kb)εwc + (1−B)(1−Kb)εwa
Kb < 1 =⇒ n > 0
The afferent signals of baroreceptors are integrated in the medulla, which generates
efferent signals to the SA node through the PSNS and SNS to moderate heart rate in
response to changes in blood pressure. According to the text [33], when blood pressure
increases, along with the afferent signal, a PSNS response is stimulated, with a concurrent
inhibition of the SNS, to decrease heart rate. Similarly, when blood pressure decreases,
along with the afferent signal, an SNS response is stimulated, with a concurrent inhibition
of the PSNS, to increase heart rate. Thus, pressure, as well as n, and PSNS activity are
positively correlated, and blood pressure, as well as n, and SNS activity are negatively
correlated. The type III functional responses given in Equations (1.20) and (1.21) model the
correlation between the afferent signal and the activation level of the PSNS and SNS due
to the Baroreflex Mechanism (Gbp and Gbs), respectively, which saturate at high and low
signals. Randall et al. [75] used a type II functional response where activation saturates only
at high signals. An activation level of 0 means that particular nervous system is completely
inhibited and an activation level of 1 means that particular nervous system is completely
stimulated. Figure 8 illustrates the behavior of Equations (1.20) and (1.21).


















Gbp = activation level of PSNS due to Baroreflex Mechanism [dimensionless]
Gbs = activation level of SNS due to Baroreflex Mechanism [dimensionless]
n = afferent signal of baroreceptors [sec−1]
qbp = sigmoid steepness constant for activation of PSNS due to Baroreflex
Mechanism [dimensionless]
qbs = sigmoid steepness constant for activation of SNS due to Baroreflex
Mechanism [dimensionless]
sbp = sigmoid shift constant for activation of PSNS due to Baroreflex
Mechanism [sec−1]
sbs = sigmoid shift constant for activation of SNS due to Baroreflex
Mechanism [sec−1]
Gbpmin = minimum activation level of PSNS due to Baroreflex Mechanism [dimensionless]
Gbsmin = minimum activation level of SNS due to Baroreflex Mechanism [dimensionless]
Since sbp, sbs, n > 0 and Gbpmin , Gbsmin ∈ [0, 1], Gbp ∈ [Gbpmin , 1] and Gbs ∈ [Gbsmin , 1].
Similar to the afferent signal, individual firing of neurons involved in the efferent signal
is not modeled. Therefore the change in the tone, or activity, over time of PSNS and SNS
due to the Baroreflex Mechanism (Tbp and Tbs), incorporating Equations (1.20) and (1.21),
is modeled by Equations (1.22) and (1.23), respectively, and describe adjustment back to












Tbp = tone of PSNS due to Baroreflex Mechanism [dimensionless]
Tbs = tone of SNS due to Baroreflex Mechanism [dimensionless]
Gbp = activation level of PSNS due to Baroreflex Mechanism [dimensionless]
Gbs = activation level of SNS due to Baroreflex Mechanism [dimensionless]
Kbp = gain constant for tone of PSNS due to Baroreflex Mechanism [dimensionless]
Kbs = gain constant for tone of SNS due to Baroreflex Mechanism [dimensionless]
τbp = time constant for tone of PSNS due to Baroreflex Mechanism [sec]
τbs = time constant for tone of SNS due to Baroreflex Mechanism [sec]
To find bounds on Tbp and Tbs, Gi ∈ [Gimin , 1] is used after integrating Equations (1.22) and




, as shown in Equations (1.24)-(1.27) for i = {bp, bs} and







































































t ∈ (0, 1) =⇒ 0 < KiGimin −KiGimine
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Thus, 0 < Tbp < Kbp and 0 < Tbs < Kbs.
Respiratory Sinus Arrhythmia
RSA is the phenomena of heart rate synchronizing with involuntary respiration. When
thoracic pressure increases during inhalation, the PSNS is inhibited. Thus thoracic pressure
and PSNS activity are negatively correlated. Similar to Equations (1.20) and (1.21), the
relationship between thoracic pressure and the activation level of the PSNS due to RSA
(Grp) can be described by the type III functional response in Equation (1.28). Randall et al.
used a type II functional response. An activation level of 0 means the PSNS is completely
inhibited and an activation level of 1 means the PSNS is completely stimulated. The behavior
of Equation (1.28) is similar to the behavior of Equation (1.21) shown in Figure 8.
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Grp = activation level of PSNS due to RSA [dimensionless]
Pth = thoracic pressure signal [mmHg]
qrp = sigmoid steepness constant for activation of PSNS due to RSA [dimensionless]
sr = sigmoid shift constant for activation of PSNS due to RSA [mmHg]
Grpmin = minimum activation level of PSNS due to RSA [dimensionless]
Since srp, Pth > 0 and Grpmin ∈ [0, 1], Grp ∈ [Grpmin , 1].
Similar to Equations (1.22) and (1.23), Equation (1.29), incorporating (1.28), shows the






Trp = tone of PSNS due to RSA [dimensionless]
Grp = activation level of PSNS due to RSA [dimensionless]
Krp = gain constant for tone of PSNS due to RSA [dimensionless]
τrp = time constant for tone of PSNS due to RSA [sec]
Using the same argument as Equations (1.24)-(1.27), 0 < Trp < Krp.
Heart Rate
Heart rate (H) is modeled as the deviation from a weighted intrinsic heart rate (HI). The
weight is based on weighted contributions from each of the nervous system branches, i.e., a
linear combination of the efferent responses due to the Baroreflex Mechanism and RSA in
Equations (1.22), (1.23), and (1.29). The intrinsic heart rate is the rate at which the heart
beats without modulation from the medulla and depends on age, as described in [42] and
shown in Equation (1.30).
HI = 118− 0.57 ∗ age (1.30)
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where
HI = intrinsic heart rate [bpm]
age = age of patient [years]
Intrinsic heart rate is nonnegative provided age ≤ 118/0.57 ≈ 207.02, which is a reasonable
assumption.
The weighted intrinsic heart rate (H̃) is given in Equation (1.31). Stimulation of a PSNS
response due to the Baroreflex Mechanism decreases heart rate, hence the negative sign in
front of the weighting constant Hbp. Stimulation of an SNS response due to the Baroreflex
Mechanism and inhibition of the PSNS due to RSA both increase heart rate, hence the
positive sign in front of both weighting parameters Hbs and Hrp.
H̃ = HI(1−HbpTbp +HbsTbs +HrpTrp) (1.31)
where
H̃ = weighted intrinsic heart rate [bpm]
Tbp = tone of PSNS due to Baroreflex Mechanism [dimensionless]
Tbs = tone of SNS due to Baroreflex Mechanism [dimensionless]
Trp = tone of PSNS due to RSA [dimensionless]
HI = intrinsic heart rate [bpm]
Hbp = weighting constant for tone of PSNS due to Baroreflex Mechanism [dimensionless]
Hbs = weighting constant for tone of SNS due to Baroreflex Mechanism [dimensionless]
Hrp = weighting constant for tone of PSNS due to RSA [dimensionless]
Since 0 < Ti < Ki for i = {bp, bs, rp} and Hbp, Hbs, and Hrp are positive, Equation (1.32) is
satisfied for the bounds of H̃, provided Hbp ≤ 1Kbp .
0 ≤ HI(1−HbpKbp) ≤ H̃ ≤ HI(1 +HbsKbs +HrpKrp) (1.32)
Equation (1.33) describes the change in heart rate over time as an adjustment back to







H = heart rate [bpm]
H̃ = weighted intrinsic heart rate [bpm]
τH = time constant for heart rate [bpm]
To find bounds on H, and show that H is nonnegative, H̃ ∈ [0, HI(1 + HbsKbs + HrpKrp)]




, as shown in Equations















H̃ ∈ [0, HI(1 +HbsKbs +HrpKrp)] =⇒ (1.35)





























t ∈ (0, 1) =⇒ 0 ≤ H(t) < HI(1 +HbsKbs +HrpKrp) (1.38)
Circulation Model
According to [39], since the heart pumps a volume of blood through the body via the
circulatory system, heart rate can be modeled by its connection to blood volume (V ). The
circulation model describes blood pressure (P ), via blood volume, as a function of heart
rate in four compartments: arterial systemic circulation (as), venous systemic circulation
(vs), arterial pulmonary circulation (ap), and venous pulmonary circulation (vp). The
compartments are made up of the large arteries and veins entering and exiting the heart.
Since large arteries and veins are primarily elastic with no resistance to blood flow, they are
considered to be compliance vessels, meaning the blood volume through the vessel is directly
proportional to the blood pressure as shown in Equation (1.39).
V = cP (1.39)
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where
V = volume of blood in vessel [L]
P = blood pressure [mmHg]
c = compliance constant [L ·mmHg−1]
The compliance of a vessel (c) describes a vessel’s ability to resist recoil toward its original
dimensions on application of a distending or compressing force. A stiff vessel has a small
compliance value while a flexible vessel has a large compliance value. Since the four
compartments of the circulation model are made up of the large arteries and veins entering
and exiting the heart, the blood volume in each compartment is described by Equations
(1.40)-(1.43).
Vas = casPas (1.40)
Vvs = cvsPvs (1.41)
Vap = capPap (1.42)
Vvp = cvpPvp (1.43)
where
Vi = volume of blood in compartment i [L]
Pi = blood pressure of compartment i [mmHg]
ci = compliance constant for compartment i [L ·mmHg−1]
i = {as, vs, ap, vp}
The change in blood volume with respect to time in a compartment will be the difference
between the blood flow into the compartment and the blood flow out of the compartment.
Blood flow into or out of the heart is termed cardiac output and is denoted by Ql and Qr
for the left side and right side of the heart, respectively. Blood flow in the body is denoted
by Fs and Fp for systemic circulation and pulmonary circulation, respectively. Blood flow
in the body refers to circulation in the smaller vessels not apart of the four compartments.
Since arterial systemic circulation carries oxygenated blood from the left side of the heart
to the body, the change in blood volume over time in the as compartment can be described
by Equation (1.44). Since venous systemic circulation carries de-oxygenated blood from
the body to the right side of the heart, the change in blood volume over time in the vs
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compartment can be described by Equation (1.45). Since arterial pulmonary circulation
carries de-oxygenated blood from the right side of the heart to the lungs, the change in
blood volume over time in the ap compartment can be described by Equation (1.46). Since
venous pulmonary circulation carries oxygenated blood from the lungs to the left side of
the heart, the change in blood volume over time in the vp compartment can be described
by Equation (1.47). The change in the blood volume over time in each compartment is
illustrated in Figure 9. The far right side of Equations (1.44)-(1.47) are divided by 60 to
convert from minutes to seconds.





(Ql − Fs) (1.44)











(Qr − Fp) (1.46)







Vi = volume of blood in compartment i [L]
Pi = blood pressure of compartment i [mmHg]
ci = compliance constant for compartment i [L ·mmHg−1]
i = {as, vs, ap, vp}
Ql = cardiac output of left side of heart [L ·min−1]
Qr = cardiac output of right side of heart [L ·min−1]
Fs = blood flow in systemic circulation [L ·min−1]
Fp = blood flow in pulmonary circulation [L ·min−1]
Cardiac output (Q) is defined as the the volume of blood pumped through a ventricle
per minute. It is the product of the heart rate (number of beats per minute) and the stroke
volume (volume of blood pumped through a ventricle per beat). The stroke volume (Vstr)
can be determined by the difference in the end-diastolic volume (Vdia) and the end-systolic
volume (Vsys) of a ventricle. The end-diastolic volume of the heart is the maximum volume
of blood and the end-systolic volume of the heart is the minimum volume of blood in the
heart during a heartbeat. The stroke volume is the difference between the maximum and
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minimum volume of blood in the heart during a heartbeat. Considering the atriums and
ventricles as compliance vessels, the stroke volume can be described by Equation (1.48).
The blood pressure of an atrium at the end of diastole (Pdia) will be equivalent to the blood
pressure of the veins supplying the atrium with blood since they are both compliance vessels.
Likewise, the blood pressure of a ventricle at the end of systole (Psys) will be equivalent to
the blood pressure of the arteries supplied with blood by the ventricle. Also, since the heart
is fully contracted (very stiff) at the end of systole, the compliance of the ventricle will be
essentially zero.
Vstr = Vdia − Vsys (1.48)
= cdiaPdia − csysPsys
= cdiaPv − csysPa
= cdiaPv
where
Vstr = stroke volume [L · beat−1]
Vdia = end-diastolic volume of relaxed atrium [L · beat−1]
Vsys = end-systolic volume of contracted ventricle [L ·min−1]
Pdia = end-diastolic blood pressure of relaxed atrium [mmHg]
Psys = end-systolic blood pressure of contracted ventricle [mmHg]
Pv = blood pressure of veins supplying artrium [mmHg]
Pa = blood pressure of arteries supplied by ventricle [mmHg]
cdia = end-diastolic compliance of relaxed atrium [L ·mmHg−1 · beat−1]
csys = end-systolic compliance of contracted ventricle [L ·mmHg−1 · beat−1]
This gives Equation (1.49) for cardiac output.
Q = HVstr = cdiaHPv (1.49)
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where
Q = cardiac output [L ·min−1]
H = heart rate [bpm]
Vstr = stroke volume [L · beat−1]
Pv = blood pressure of veins supplying artrium [mmHg]
cdia = end-diastolic compliance of relaxed atrium [L ·mmHg−1 · beat−1]
Since the venous pulmonary compartment is the compartment that supplies the atrium of
the left side of the heart, Equation (1.50) describes the cardiac output of the left side of the
heart. Likewise, since the venous systemic compartment is the compartment that supplies
the atrium of the right side of the heart, Equation (1.51) describes the cardiac output of the
right side of the heart.
Ql = clHPvp (1.50)
Qr = crHPvs (1.51)
where
Ql = cardiac output of left side of heart [L ·min−1]
Qr = cardiac output of right side of heart [L ·min−1]
H = heart rate [bpm]
Pvp = blood pressure of compartment vp [mmHg]
Pvs = blood pressure of compartment vs [mmHg]
cl = end-diastolic compliance of relaxed left atrium [L ·mmHg−1 · beat−1]
cr = end-diastolic compliance of relaxed right atrium [L ·mmHg−1 · beat−1]
Blood flow in the body (F ) takes place in smaller vessels, such as arterioles, capillaries,
and venules, that are rigid with resistance to blood flow. These vessels are considered to be
resistance vessels, meaning volume of blood is not proportional to blood pressure. A simple
relationship to describe vessels of this sort is Ohm’s Law. Ohm’s Law states that the potential
difference, or voltage, across a conductor is proportional to the current through it, with the
resistance of the conductor as the constant of proportionality. Applied to circulation, the
difference in blood pressure between two points in a vessel is proportional to the blood flow
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through the vessel, with the resistance to blood flow (R) as the constant of proportionality.
This is described in Equation (1.52). Blood flows out of the heart via arteries (large vessels),
then flows through arterioles (small vessels), capillaries (even smaller vessels), venules (small
vessels), and back to the heart via veins (large vessels). The two points in consideration are
arterioles to venules.
R · F = Pa − Pv (1.52)
=⇒ F = Pa − Pv
R
where
F = blood flow in circulation [L ·min−1]
Pa = blood pressure of arterioles [mmHg]
Pv = blood pressure of venules [mmHg]
R = resistance to blood flow in circulation [mmHg ·min · L−1]
In systemic circulation, arterioles have the same blood pressure as the arteries supplying
them with blood, or the as compartment. Likewise, venules have the same blood pressure
as the veins they supply with blood, or the vs compartment. Thus blood flow in systemic
circulation (Fs) is described by Equation (1.53). In pulmonary circulation, arterioles have
the same blood pressure as the arteries supplying them with blood, or the ap compartment.
Likewise, venules have the same blood pressure as the veins they supply with blood, or the












Fs = blood flow in systemic circulation [L/min]
Fp = blood flow in pulmonary circulation [L/min]
Pas = blood pressure of compartment as [mmHg]
Pvs = blood pressure of compartment vs [mmHg]
Pap = blood pressure of compartment ap [mmHg]
Pvp = blood pressure of compartment vp [mmHg]
Rs = resistance to blood flow in systemic circulation [mmHg ·min/L]
Rp = resistance to blood flow in pulmonary circulation [mmHg ·min/L]
Substituting Equations (1.50) and (1.51) in for Ql and Qr, respectively, and Equations
(1.53) and (1.54) in for Fs and Fp, respectively, into Equations (1.44)-(1.47) gives the system


































1.5.2 Parameterization of HRV Model
Model parameters are described below and summarized in Table 3. The following parameter
values are taken from Randall et al. [75]: A, Kb, Kbp, Kbs, Krp, τb, τbp, τbs, τrp, and τH . The
following parameter values are taken from Li et al. [57]: cas, cvs, cap, cvp, cl, cr, Rs, Rp and
Vtot. The following parameter values are varied, as explained in Section 1.6, to explore their
effect on model dynamics: B, qw, qbp, qbs, qrp, Hbp, Hbs, and Hrp. It is assumed that the
PSNS and SNS can be completely inhibited, so Gbpmin = Gbsmin = Grpmin = 0.
Initial conditions for the variables described in Table 1 and the following parameters are
derived below: sw, sbp, sbs, and srp. Since the model in this study is formulated to describe a
healthy system at rest, initial conditions and parameters values are derived from the system
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in homeostasis (derivatives are zero) at average arterial systemic blood pressure and average
thoracic pressure.
The parameter sw is chosen to be the average value of Pc = Pas, as described by Equations
(1.9)-(1.15), and calculated as the average of the arterial systemic blood pressure signal, or
MAP data. At average arterial systemic blood pressure and thoracic pressure, Equations






























= 0 =⇒ ε∗ba = Kbε∗wa (1.59)
n∗ = B(ε∗wc − ε∗bc) + (1−B)(ε∗wa − ε∗ba) (1.60)
where
P ∗c = average of blood pressure signal [mmHg]
P ∗th = average of thoracic pressure signal [mmHg]
εwc = arterial wall strain of carotid sinuses [dimensionless]
εwa = arterial wall strain of aortic arch [dimensionless]
εbc = strain of carotid baroreceptors [dimensionless]
εba = strain of aortic baroreceptors [dimensionless]
n = afferent signal of baroreceptors [sec−1]
A = maximally stressed to unstressed arterial cross-sectional area ratio [dimensionless]
B = linear combination constant for afferent signal of baroreceptors [sec−1]
qw = sigmoid steepness constant for wall strain [dimensionless]
Kb = gain constant for strain of baroreceptors [dimensionless]
τb = time constant for strain of baroreceptors [sec]
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The parameters sbp and sbs are chosen so that the activation levels of the PSNS and SNS
due to the Baroreflex Mechanism are 0.8 and 0.2, respectively, at average arterial systemic
blood pressure and thoracic pressure, i.e., Gbp = 0.8 and Gbs = 0.2, as given in Equations
(1.61) and (1.62). Also, at average arterial systemic blood pressure and thoracic pressure
Equations (1.63) and (1.64) are satisfied, where ∗ denotes the homeostatic value of a variable.



































= 0 =⇒ T ∗bs = KbsG∗bs (1.64)
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where
n = afferent signal of baroreceptors [sec−1]
Gbp = activation level of PSNS due to Baroreflex Mechanism [dimensionless]
Gbs = activation level of SNS due to Baroreflex Mechanism [dimensionless]
Tbp = tone of PSNS due to Baroreflex Mechanism [dimensionless]
Tbs = tone of SNS due to Baroreflex Mechanism [dimensionless]
qbp = sigmoid steepness constant for activation of PSNS due to Baroreflex
Mechanism [dimensionless]
qbs = sigmoid steepness constant for activation of SNS due to Baroreflex
Mechanism [dimensionless]
sbp = sigmoid shift constant for activation of PSNS due to Baroreflex
Mechanism [dimensionless]
sbs = sigmoid shift constant for activation of SNS due to Baroreflex
Mechanism [dimensionless]
Gbpmin = minimum activation level of PSNS due to Baroreflex Mechanism [dimensionless]
Gbsmin = minimum activation level of SNS due to Baroreflex Mechanism [dimensionless]
Kbp = gain constant for tone of PSNS due to Baroreflex Mechanism [dimensionless]
Kbs = gain constant for tone of SNS due to Baroreflex Mechanism [dimensionless]
τbp = time constant for tone of PSNS due to Baroreflex Mechanism [sec]
τbs = time constant for tone of SNS due to Baroreflex Mechanism [sec]
The parameter srp is chosen so that the activation level of the PSNS due to RSA is 0.5,
respectively, at average arterial systemic blood pressure and thoracic pressure, i.e., Grp = 0.5,
as given in Equation (1.65). Also, at average arterial systemic blood pressure and thoracic
pressure Equations (1.66)-(1.68) are satisfied, where ∗ denotes the homeostatic value of a
variable.
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= 0 =⇒ T ∗rp = K∗rpG∗rp (1.66)




= 0 =⇒ H∗ = H̃∗ (1.68)
where
P ∗th = average of thoracic pressure signal [mmHg]
Grp = activation level of PSNS due to RSA [dimensionless]
Tbp = tone of PSNS due to Baroreflex Mechanism [dimensionless]
Tbs = tone of SNS due to Baroreflex Mechanism [dimensionless]
Trp = tone of PSNS due to RSA [dimensionless]
H̃ = weighted intrinsic heart rate [bpm]
H = heart rate [bpm]
qrp = sigmoid steepness constant for activation of PSNS due to RSA [dimensionless]
srp = sigmoid shift constant for activation of PSNS due to RSA [mmHg]
Grpmin = minimum activation level of PSNS due to RSA [dimensionless]
Krp = gain constant for tone of PSNS due to RSA [dimensionless]
τrp = time constant for tone of PSNS due to RSA [sec]
τH = time constant for heart rate [bpm]
HI = intrinsic heart rate [bpm]
Hbp = weighting constant for tone of PSNS due to Baroreflex Mechanism [dimensionless]
Hbs = weighting constant for tone of SNS due to Baroreflex Mechanism [dimensionless]
Hrp = weighting constant for tone of PSNS due to RSA [dimensionless]
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Initial conditions of εbc, εba, Tbp, Tbs, and Trp are the homeostatic values at average arterial
systemic blood pressure and thoracic pressure. The initial condition of Pas is the average of
the arterial systemic blood pressure signal, or MAP data. The initial condition of H is the
value of the heart data at the first time point.
At average arterial systemic blood pressure, Equations (1.69)-(1.72) are satisfied, where
∗ denotes the homeostatic value of a variable.
(1.55) = 0 =⇒
clH
∗P ∗vp =



















Pi = blood pressure of compartment i [mmHg]
ci = compliance constant for compartment i [L ·mmHg−1]
i = {as, vs, ap, vp}
H = heart rate [bpm]
cl = end-diastolic compliance of relaxed left atrium [L ·mmHg−1 · beat−1]
cr = end-diastolic compliance of relaxed right atrium [L ·mmHg−1 · beat−1]
Rs = resistance to blood flow in systemic circulation [mmHg ·min/L]
Rp = resistance to blood flow in pulmonary circulation [mmHg ·min/L]
Also, since circulation is a closed loop, the sum of the volumes of blood in the four
compartments will be constant, as given in Equation (1.73).
Vtot = Vas + Vvs + Vap + Vvp (1.73)
= casPas + cvsPvs + capPap + cvpPvp
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where
Vtot = total blood volume [L]
Vi = volume of blood in compartment i [L]
Pi = blood pressure of compartment i [mmHg]
ci = compliance constant for compartment i [L ·mmHg−1]
i = {as, vs, ap, vp}




vp gives the homeostatic values in
Equations (1.74)-(1.76) and are the initial conditions for Pvs, Pap, and Pvp.
P ∗vp =
cr(VtotRs − (casRs + capRp)P ∗as)













Pi = blood pressure of compartment i [mmHg]
ci = compliance constant for compartment i [L ·mmHg−1]
i = {as, vs, ap, vp}
cl = end-diastolic compliance of relaxed left atrium [L ·mmHg−1 · beat−1]
cr = end-diastolic compliance of relaxed right atrium [L ·mmHg−1 · beat−1]
Rs = resistance to blood flow in systemic circulation [mmHg ·min/L]
Rp = resistance to blood flow in pulmonary circulation [mmHg ·min/L]
Vtot = total blood volume [L]
1.5.3 HRV Model
Heart rate is modeled by the system of ODEs in Equation (1.77) with auxiliary Equations
(1.7), (1.8), (1.14), (1.15), (1.19), (1.20), (1.21), (1.28), (1.30), and (1.31) where ′ denotes
differentiation with respect to time, that describes neuroendocrine control of heart via the
Baroreflex Mechanism and RSA, and heart rate as a driver of circulation. Model variables
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are summarized in Table 1, auxiliary variables are summarized in Table 2, and parameters




















































The solution to Equation (1.77) is simulated by the ODE solver ode15s in MATLAB [62],
a numerical method for stiff ODE systems. Figure 10 shows the numerical solution of the
HRV model described by the system of ODEs in Equation (1.77) compared to patient data.
The numerical solution shows the time courses of the system variables from Table 1 with
reference parameter values from Table 3. Initial conditions are described in Section 1.5.2.
Figure 11 shows a larger plot of the numerical solution of the model predicted heart rate
(H).
1.5.4 Metrics of HRV
The solution of the HRV model, particularly model predicted heart rate (H) and arterial
systemic blood pressure (Pas), are compared to heart rate and MAP data. The data is not
used to validate the model. Instead, it is used to provide a visual and numerical projection
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for the model output. Numerically, the model is compared to the data by two metrics: the
mean of heart rate and the variance of the RR intervals of heart rate.
As described in Section 1.2.1, an RR interval is the time interval between two consecutive
R waves on an ECG. Also, heart rate is derived from an ECG by dividing 60 by the duration
of the RR interval at each time point. Thus, the RR intervals for the model predicted heart
rate can be found by dividing 60 by the heart rate at each time point, as described by






RR = duration of RR interval [sec]
H = heart rate [bpm]
The the mean of heart rate and the variance of the RR intervals of heart rate for the
heart rate data and the model predicted heart rate are summarized in Table 4.
1.6 Results
The effect of several parameters on the model output, the mean of heart rate, and the variance
of the RR intervals of heart rate was explored. The parameter values explored included the
sigmoid steepness constants (qw, qbp, qbs, and qrp), the weighting constants (Hbp, Hbs, and
Hrp), and the linear combination constant (B), and were chosen because their values were
not available in literature, could not be calculated from patient data, and appear to have a
significant effect on the model output. Results are summarized in Table 4 and Figures 12-19.
The solution to the system of ODEs in Equation (1.77) with reference parameter values
in Table 3 and initial conditions described in Section 1.5.2 is shown in Figures 10 and 11.
There is more variability in the strain of the aortic baroreceptors (εba), which incorporates
respiration via thoracic pressure, than in the strain of the carotid baroreceptors (εbc), which
does not incorporate respiration via thoracic pressure. There is also more variability in
the tone of the PSNS due to RSA (Trp) than the tone of the PSNS and SNS due to the
Baroreflex Mechanism (Tbp and Tbs), and more variability in Tbp than Tbs. Thus, it appears
that signals incorporating respiration via thoracic pressure have more variability than the
signals that do not, and may be the source of variability in the heart rate signal (H).
Parameter exploration further supports this as described below. The model predicted arterial
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systemic blood pressure (Pas) is higher than the data and has more variability than the other
model predicted blood pressures. Model predicted venous systemic, arterial pulmonary, and
venous pulmonary blood pressures (Pvs, Pap, and Pvp) follow average values of 5-8 mmHg,
8-20 mmHg, and 8 mmHg, respectively, from literature [33]. The mean of the heart rate
data is 68.394 bpm and the mean of the model predicted heart rate (H) is 69.836 bpm. The
variance of the RR intervals for the heart rate data is 0.00227 bpm2 and the variance of the
RR intervals for the model predicted heart rate (H) is 0.00102 bpm2. Thus, the model is
able to capture the order of magnitude of HRV in the data.
The sigmoid steepness constant for arterial wall strain (qw) determines how quickly cross-
sectional area of an artery distends as blood pressure increases. Since pressure and volume
are directly proportional in large vessels like the carotid sinuses and aortic arch, an increase
in blood pressure in an artery causes an increase in the volume of blood in that artery. If
qw is small, distension is slow and cross-sectional area is not as large for higher pressures.
Thus, the heart beats faster to pump the larger volume of blood through the artery. Also,
slower distension results in slower changes in baroreceptor strain and a slower afferent signal,
causing a slower PSNS and SNS response via the Baroreflex Mechanism to bring heart rate
back down. If qw is large, the opposite occurs. Thus, mean heart rate decreases as qw
increases in Table 4. Also, if qw is small, causing a higher heart rate (H), arterial systemic
blood pressure (Pas) will be larger. A larger arterial systemic blood pressure causes the
Baroreflex Mechanism to stimulate the PSNS and inhibit the SNS responses, producing a
larger Tbp and a smaller Tbs. Since Tbp has more variability than Tbs, HRV will be larger. If qw
is large, the opposite occurs. Thus, the variance in the RR intervals of heart rate increases
as qw decreases in Table 4. Figure 12 shows the model predicted heart rate compared to
heart rate data for increasing values of qw.
The sigmoid steepness constant for the activation of the PSNS due to the Baroreflex
Mechanism (qbp) determines how quickly the level of PSNS activation increases as the afferent
signal increases. An increasing afferent signal indicates increasing baroreceptor strain from
increasing blood pressure. If qbp is small, the PSNS is not being stimulated as quickly to
lower heart rate. If qbp is large, the PSNS is being stimulated quickly to lower heart rate.
Thus, mean heart rate decreases as qbp increases in Table 4. Also, if qbp is small and the PSNS
is not being stimulated as quickly, and thus the SNS is not being inhibited as quickly, Tbp will
be small and Tbs will be large. Since Tbs has less variability than Tbp, HRV will be smaller.
If qbp is large, the opposite occurs. However, very large values of qbp produce a smaller heart
rate (H), which in turn produces a smaller arterial systemic blood pressure (Pas). A smaller
arterial systemic blood pressure causes the Baroreflex Mechanism to inhibit the PSNS and
stimulate the SNS responses, producing a smaller Tbp and larger Tbs. Therefore, HRV will
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be smaller. Thus, the variance in the RR intervals of heart rate increases as qbp is closer to
middle values in Table 4. Figure 13 shows the model predicted heart rate compared to heart
rate data for increasing values of qbp.
The sigmoid steepness constant for the activation of the SNS due to the Baroreflex
Mechanism (qbs) determines how quickly the level of SNS activation decreases as the afferent
signal increases. An increasing afferent signal indicates increasing baroreceptor strain from
increasing blood pressure. If qbs is small, the SNS is not being inhibited as quickly to lower
heart rate. If qbs is large, the SNS is being inhibited quickly to lower heart rate. Thus,
mean heart rate decreases as qbs increases in Table 4. Also, if qbs is small and the SNS is not
being inhibited as quickly, and thus the PSNS is not being stimulated as quickly, Tbs will be
larger and Tbp will be smaller. Since Tbs has less variability than Tbp, HRV will be smaller.
If qbs is large, the opposite occurs. However, very large values of qbs produce a smaller heart
rate (H), which in turn produces a smaller arterial systemic blood pressure (Pas). A smaller
arterial systemic blood pressure causes the Baroreflex Mechanism to inhibit the PSNS and
stimulate the SNS responses, producing a smaller Tbp and larger Tbs. Therefore, HRV will
be smaller. Thus, the variance in the RR intervals of heart rate increases as qbs is closer to
middle values in Table 4. Figure 14 shows the model predicted heart rate compared to heart
rate data for increasing values of qbs.
The sigmoid steepness constant for the activation of the PSNS due to RSA (qrp)
determines how quickly the level of PSNS activation decreases as thoracic pressure increases.
An increasing thoracic pressure indicates inhalation. If qrp is small, the PSNS is not being
inhibited as quickly to raise heart rate. If qrp is large, the PSNS is being inhibited quickly
to raise heart rate. If qrp is 0, the PSNS is almost not responding to changes in thoracic
pressure and is not contributing to changes in heart. Thus, mean heart rate decreases as qrp
increases, except for when qrp is 0, in Table 4. Changes in mean heart rate due to variation
in qrp are not as large as changes in mean heart rate due to variation in qbp or qbs because the
activation of the PSNS due to RSA only has small, transient effects on heart rate whereas
activation of the PSNS and SNS due to the Baroreflex Mechanism acts directly on heart
rate. Also, if qrp is small, Trp will be smaller. Since Trp has more variability than Tbp and
Tbs, HRV will be smaller. If qrp is large, the opposite occurs. Thus, the variance in the
RR intervals of heart rate increases as qrp increases in Table 4. Figure 15 shows the model
predicted heart rate compared to heart rate data for increasing values of qrp.
The weighting constant Hbp determines the relative contribution of the tone of the PSNS
due to the Baroreflex Mechanism (Tbp) to heart rate. Since stimulation of a PSNS response
due to the Baroreflex Mechanism decreases heart rate, if Hbp is small, Tbp contributes less
to heart rate and heart rate is decreased less. If Hbp is large, Tbp contributes more to heart
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rate and heart rate is decreased more. Thus, mean heart rate decreases as Hbp increases in
Table 4. Also, since Tbp has more variability than Tbs, if Hbp is small, Tbp contributes less
to heart rate, allowing Tbp to contribute more to heart rate, and HRV will be smaller. If
Hbp is large, Tbp contributes more to heart rate, allowing Tbs to contribute less to heart rate,
and HRV will be larger. However, since Tbp has less variability than Trp, if Hbp is small, Tbp
contributes less to heart rate, allowing Trp to contribute more to heart rate, and HRV will
be larger. If Hbp is large, Tbp contributes more to heart rate, allowing Trp to contribute less
to heart rate, and HRV will be smaller. Thus, the variance in the RR intervals of heart rate
increases as Hbp is closer to middle values in Table 4. Figure 17 shows the model predicted
heart rate compared to heart rate data for increasing values of Hbp.
The weighting constant Hbs determines the relative contribution of the tone of the SNS
due to the Baroreflex Mechanism (Tbs) to heart rate. Since stimulation of an SNS response
due to the Baroreflex Mechanism increases heart rate, if Hbs is small, Tbs contributes less to
heart rate and heart rate is increased less. If Hbs is large, Tbs contributes more to heart rate
and heart rate is increased more. Thus, mean heart rate increases as Hbs increases in Table
4. Also, since Tbs has less variability than Tbp and Trp, if Hbs is small, Tbs contributes less to
heart rate, allowing Tbp and Trp to contribute more to heart rate, and HRV will be larger.
If Hbs is large, Tbs contributes more to heart rate, allowing Tbp and Trp to contribute less to
heart rate, and HRV will be smaller. However, very large values of Hbs produce a larger heart
rate (H), which in turn produces a larger arterial systemic blood pressure (Pas). A larger
arterial systemic blood pressure causes the Baroreflex Mechanism to stimulate the PSNS
and inhibit the SNS responses, producing a smaller Tbs. Therefore, even though Hbs is very
large, Tbs is small and the heart rate signal is more due to Tbp and Trp, which contain more
variability. Thus, the variance in the RR intervals of heart rate increases as Hbs further away
from middle values in Table 4. Figure 17 shows the model predicted heart rate compared to
heart rate data for increasing values of Hbs.
The weighting constant Hrp determines the relative contribution of the tone of the PSNS
due to RSA (Trp) to heart rate. Since inhibition of a PSNS response due to RSA increases
heart rate, if Hrp is small, Trp contributes less to heart rate and heart rate is increased less.
If Hrp is large, Trp contributes more to heart rate and heart rate is increased more. Thus,
mean heart rate increases as Hrp increases in Table 4. Also, since Trp has more variability
than Tbp and Tbs, if Hrp is small, Trp contributes less to heart rate and HRV will be smaller.
If Hrp is large, Trp contributes more to heart rate and HRV will be larger. Thus, the variance
in the RR intervals of heart rate increases as Hrp increases in Table 4. Figure 18 shows the
model predicted heart rate compared to heart rate data for increasing values of Hrp.
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The linear combination constant (B) determines the relative contribution of carotid and
aortic baroreceptor strain to the afferent signal (n). If B ∈ [0, 0.5), aortic baroreceptor strain
contributes more to n. If B ∈ (0.5, 1], carotid baroreceptor strain contributes more to n.
If B = 0.5, carotid and aortic baroreceptor strain contributes evenly to n. There is not a
significant change in the mean heart rate for different values of B in Table 4 because PSNS
and SNS tone due to the Baroreflex Mechanism, and thus heart rate, responds the same to
the afferent signal regardless of how the signal is formulated from different locations in the
body. HRV is larger for B = 1, when n is only a function of carotid baroreceptor strain, than
for B = 0, when n is only a function of aortic baroreceptor strain, as summarized in Table
4, which is a counterintuitive result. More variability in aortic baroreceptor strain (εba) than
in carotid baroreceptor strain (εbc) supports the opposite result. Figure 19 shows the model
predicted heart rate compared to heart rate data for increasing values of B.
1.7 Discussion
The correlation between loss of HRV and physiological states of stress has not been fully
linked to underlying physiological mechanisms, preventing the broad use of this noninvasive,
diagnostic metric of health. To gain a better understanding of the physiological mechanisms
governing HRV, this thesis combined two previous mathematical models of neuroendocrine
control of heart rate and circulation to explain the source of heart rate variability in a
resting, healthy state. Respiration was also incorporated as a disturbance to the system to
characterize the role of respiration in heart rate variability. The treatment of respiration in
this study was novel in the incorporation of a respiration-derived thoracic pressure signal
into the Baroreflex Mechanism and RSA. Also, this study was unique in the exploration of
the source of HRV in a healthy, resting state rather than the loss of HRV in a stressed state.
Results show that the mean of the heart rate data is 68.394 bpm and the mean of the
model predicted heart rate is 69.836 bpm. The variance of the RR intervals for the heart
rate data is 0.00227 bpm2 and the variance of the RR intervals for the model predicted heart
rate is 0.00102 bpm2. Thus, the model is able to capture the order of magnitude of HRV
in the data. Results also show that the mean heart rate decreases as the sigmoid steepness
constants qw, qbp, qbs, and qrp increase, as the weighting constant Hbp increases, and as the
weighting constants Hbs and Hrp decrease. Additionally, the variance of the RR intervals
for heart rate, a metric for HRV, increases as qw decreases, as qbp, qbs, and Hbp are closer to
middle values, as qrp, Hrp, and B increase, and as Hbs is further away from middle values.
This indicates that there appears to be a trade-off occurring for most parameters associate
with the Baroreflex Mechanism. HRV is higher in scenarios that do not produce extreme
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heart rate and blood pressure values. For the parameters associated with RSA, a direct
correlation between the parameter values and HRV indicates that RSA contributes to higher
RSA.
The model in this study has a few notable limitations. First, the model was not fit to
the data to determine the best values for the unknown parameter values and sensitivity
analysis was not performed to determine which parameters had a significant impact on the
outcome of the model. The combination of fitting the model to the data and sensitivity
analysis could better drive the exploration of the effect of parameters on the model output.
Second, although the incorporation of respiration was novel in this model, it is rudimentary.
There is still a large gap in the understanding of neuroendocrine control of respiration and
its link to heart rate. Thus an afferent signal due to RSA was not incorporated in this model.
Also, the effects of respiration on the circulation component of the model was not explored.
Third, the counterintuitive result of larger HRV when the afferent signal did not incorporate
aortic baroreceptor strain is not understood from the formulation of this model. Further
exploration of the formulation of the afferent signal and more metrics of HRV could help
make this result more clear.
The appearance of trade-offs in the results of this thesis mimic the type of results
in Li et al. [57]. In future work, this model could be viewed as a control system,
penalized from deviating from homeostasis, to rigorously describe the trade-offs occurring
between maintaining homeostatic values and deviations from homeostasis during respiration.
Exaggerated, but healthy, data, such as the exercise data from Li et al. [57] and the Valsalva
Maneuver data from Randall et al. [75], could be used to force a more exaggerated model
output and help validate the model. Ultimately, this thesis has demonstrated the need to




The Contribution of Environmental
Pathways to Clostridioides difficile
Transmission
2.1 Introduction
Transmission of a pathogen between hosts is the most important process driving the
dynamics of an infectious disease. However, transmission is difficult to study. Transmission
events are unobservable and are influenced by multiple interacting factors. Mathematical
models provide a framework to investigate complex interactions driving transmission, study
infectious disease dynamics, evaluate control interventions, and design surveillance strategies.
Such mathematical models are termed epidemiological models. The aim of this study
is to formulate an epidemiological model to investigate the contribution of environmental
pathways to the transmission of Clostridioides difficile (abbreviated C. diff ) in healthcare
settings.
C. diff is the leading cause of infectious diarrhea and is the most frequently identified
healthcare-associated, i.e., nosocomial, infection in United States hospitals. C. diff is
typically contracted after antibiotic use, when a healthy gut microbiota that prevents
colonization is compromised. Colonized patients, both symptomatic and asymptomatic,
shed endospores that survive for long periods of time on surfaces outside the host and are
resistant to commonly used disinfectants. Transmission pathways can include contact with
environmental reservoirs of endospores on fomites, objects and surfaces that can harbor
infectious agents.
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The difficulty in studying environmental transmission of nosocomial pathogens, a lack
of understanding of these dynamics, and the serious nature of C. diff infections hinders the
ability to control certain nosocomial infections, including C. diff infections. This study adds
environmental reservoirs to a previous epidemiological model of C. diff transmission and
focuses on the effect of fomite touch frequency on C. diff transmission. Specifically, this
study investigates the contribution of high-touch frequency and low-touch frequency fomites
in a hospital ward to new cases of C. diff colonization among hospital patients. Additionally,
this study determines the factors that influence their relative contributions.
The dynamics of transmission are modeled deterministically using a six-dimensional
system of ODEs representing the four patient population classes: resistant individuals
(R), susceptible individuals (S), asymptomatically colonized individuals (C), and diseased
individuals (D), and the two pathogen environmental reservoirs: pathogen density on high-
touch frequency fomites (PH) and pathogen density on low-touch frequency fomites (PL).
Due to the small population size of 30 beds in the considered hospital ward, the system is also
simulated stochastically using the Gillespie Stochastic Simulation Algorithm (GSSA) and
the results are compared to the average population behavior described by the deterministic
system.
Results show that on average, over three-quarters of asymptomatically colonized patients
are colonized due to a contact with a high-touch frequency fomite and under one-quarter are
colonized due to a contact with a low-touch fomite, despite the extra daily cleaning high-
touch frequency fomites receive. Individual trajectories of the system from the stochastic
simulations showed behaviors and extreme cases not captured by the deterministic system.
This project was supported by the joint Division of Mathematical Sciences and National
Institute of General Medical Sciences Mathematical Biology Program through the National
Institute of Health award #R01GM113239. This is joint work with Dr. Cristina Lanzas
(PI) of North Carolina State University, her previous student Ms. Hannah Ritchie, and Dr.
Judy Day (co-PI), Dr. Suzanne Lenhart (co-PI), and Ms. Cara Sulyok of the University of
Tennessee, Knoxville.
2.2 Background
2.2.1 Natural History of C. diff Infection
Clostridioides difficile (formerly Clostridium difficile [52]) is an anaerobic, gram-positive
bacillus spread among humans via the fecal-oral route. C. diff is of particular interest because
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it is the leading cause of infectious diarrhea and is the most frequently identified healthcare-
associated infection in United States hospitals [55]. It was first identified in the 1930s by [35],
who named the bacterium Bacillus difficilis due to the difficulty of culturing the bacterium
in vitro. It was originally thought that the relationship between humans and the bacterium
was commensal [35] since most infants have C. diff present in their gut (are colonized) but
do not display any symptoms (are not diseased) [77]. However, subsequent studies began
to indicate otherwise, leading to recent data that demonstrates the serious nature of the
disease. In 2008, it was estimated that C. diff may have been responsible for an extra $4.8
billion in healthcare costs in the United States that year [23]. In 2011, it was estimated that
453,000 C. diff infections and 29,300 C. diff -associated deaths occurred in the United States
that year [55]. In 2013, the Centers for Disease Control and Prevention (CDC) published an
analysis of the top antibiotic-resistant threats in the United States, classifying the threats
according to their current and projected health and economic impacts. C. diff was classified
at the highest rank of ‘Urgent Threat’, requiring immediate and aggressive public health
action [15].
According to [56], C. diff produces endospores: non-reproductive, metabolically inactive
structures able to survive harsh conditions such as high temperatures and acidic environ-
ments for several weeks or months. Spores can survive in water and are resistant to most
commonly used disinfectants. When ingested, spores survive the environment of the stomach
and travel to the large intestine. In individuals with a diverse gut microbiota, spores do not
germinate and remain in the colon as a commensal species, causing no harm or symptoms
for the host. In individuals without a diverse gut microbiota, the absence of competition
with other bacteria for resources in the gut stimulate spores to germinate: become active,
reproducing, vegetative cells. Such individuals are termed colonized. However, if the host
is able to mount an appropriate immune response against toxins produced by vegetative
cells, they do not experience symptoms of colonization. Such individuals are termed
asymptomatically colonized. If the host is not be able to mount an appropriate immune
response, vegetative cells adapt to their new environment on the interior walls of the colon.
This adaption includes remodeling structural components of their cell wall that degrade
the lining of the colon and releasing exotoxins TcdA and TcdB. Toxins TcdA and TcdB
cause fluid accumulation and inflammation of the colon, termed colitis. Symptoms of
colitis due to C. diff colonization without an appropriate immune response include diarrhea,
abdominal pain and cramps, nausea, vomiting, dehydration, malaise, fever, and leukocytosis.
Symptomatically colonized individuals are termed infectious or diseased.
Since the prevention of the germination of C. diff spores in the colon is primarily due
to the presence of a diverse gut microbiota, recent antibiotic use, which compromises gut
42
microbiota, is the principle risk factor for colonization. Although the primary antibiotics
associated with colonization are ampicillin, amoxicillin, cephalosporins, clindamycin, and
fluoroquinolones, all antibiotics have been linked to C. diff colonization, even those used to
treat C. diff infection [54]. Symptoms typically start displaying one week after antibiotic use
[22] and 85-90% of infections occur within 30 days of antibiotic use [16]. Most infections are
healthcare-associated due to patient clustering, the large proportion of elderly patients, and
the large proportion (30-40%) of patients using antibiotics [54].
Metronidazole and vancomycin have been the primary antibiotics used to treat patients
with C. diff infection since the 1970s [54]. Fidaxomicin was approved by the Food and Drug
Administration (FDA) in 2011 as another possible antibiotic treatment [54]. A 10-14 day
treatment is successful in approximately 50% of cases [40, 53]. Since recent antibiotic use
is the principle risk factor for colonization, recurrent infections are likely. There is a 20%
chance of a recurrent infection after the initial infection and a 60% chance after multiple
prior infections [27, 64]. Risk factors for a recurrent C. diff infection include ongoing use of
antibiotics not associated with C. diff infection and a severe initial infection [64]. Due to
the persistence of spores and an ineffective immune response, not antibiotic resistance, it is
difficult to treat subsequent recurrent infections [61]. Multiple recurrent infections result in
severe colitis. Severe colitis can lead to colon perforation and the need for an emergency
colectomy, which is associated with an 80% mortality rate [66]. The most effective way
to eliminate C. diff from the gut is to cease all antibiotics and allow the gut microbiota
to recover spontaneously, however gut restoration may take up to 12 weeks, during which
patients may experience recurrent infections [25].
There is no effective vaccination against the toxins TcdA and TcdB released by the
bacteria, but as of 2017 three candidate vaccines are undergoing clinical evaluation for C.
diff infection prevention [89].
2.2.2 Environmental Pathways of C. diff Transmission
Evidence suggests that transmission pathways of C. diff infection include compulsorily
interacting with fomites in healthcare settings [69, 70]. Colonized patients, both symptomatic
and asymptomatic, shed C. diff spores that can survive for long periods on surfaces outside
the host and can spread to other surfaces via hands of patients, visitors, and healthcare
workers [29, 47]. A study by [4] swabbed fomites in patient rooms and bathrooms, nurses
stations, and utility rooms in a hospital. They found that 74% of surfaces tested in the
vicinity of infected patients were contaminated with C. diff spores. They also found that 29%
of all surfaces tested in a case ward, including surfaces beyond patient areas such as utility
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room sinks and chair arms, and 90% of floors tested in a case ward were contaminated with
C. diff spores. An analysis by [91] found that frequency of C. diff infections is correlated with
the frequency of C. diff recovered from environmental surfaces in rooms of diseased patients.
A study by [24] surveyed six healthcare facilities and found that rooms of colonized patients
were more likely to be contaminated than rooms of non-colonized patients. An investigation
by [82] tracked patients admitted over six months into an intensive care unit. Of the patients
who acquired infection, 11% occupied a room that was previously occupied by a patient with
C. diff infection, whereas 4.6% occupied a room that was previously occupied by a patient
without C. diff infection. They suggested that a room housing a patient infected with C. diff
had a significant effect on the acquisition of infection by the subsequent occupant. A study
by [90] documented C. diff environmental contamination after cleaning rooms of infected
patients. They found that room contamination and C. diff infection rates decreased over
four weeks of effective cleaning. An analysis by [68] evaluated daily cleaning with bleach
wipes in hospital wards with high-incidence of C. diff infection. The intervention reduced
incidence by 85%.
The acknowledgment of the importance of environmental reservoirs in the transmission
of C. diff infection has resulted in an influx of research on the most effective cleaning
and disinfecting methods. The most effective chemical for killing C. diff spores is a
chlorine-derived disinfectant [58], while non-chlorine-derived chemicals may stimulate spore
production [93]. The CDC recommends daily cleaning of the immediate vicinity around an
infected patient, including toilets, and disinfecting of an infected patient’s entire room upon
transfer or discharge [36, 79]. Disinfecting should utilize a disinfectant or sporicide from the
Environmental Protection Agency’s (EPA) List K, which comprises chlorine-derived cleaners
effective against C. diff spores [26]. The CDC also recommends considering additional
disinfection with no-touch technologies, such as UV light and hydrogen peroxide systems
[36, 79].
Compliance with these guidelines is often suboptimal. In a study by [12], rooms in sixteen
intensive care units were evaluated after at least two patients had occupied a room with
disinfecting upon each discharge. They found that only 57.1% of tested sites were effectively
cleaned. An investigation by [81] swabbed fomites highly interacted with by patients in nine
acute-care hospitals and two long-term care facilities in four states to determine the typical
microbial burden on high-touch surfaces after daily cleaning and disinfecting upon discharge.
They observed that after daily cleaning, 34% of sites tested still contained pathogen and after
disinfecting upon discharge, 17% of sites tested still contained pathogen.
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Suboptimal cleaning may be due to the variation in cleaning protocols for different parts
of hospital rooms. The CDC’s Guidelines for Environmental Infection Control in Health-
Care Facilities [36] and the CDC’s Guideline for Disinfection and Sterilization in Healthcare
Facilities [79] include recommended cleaning strategies for a variety of fomites: high-touch
surfaces in patient rooms and bathrooms (i.e. bed rails, tray table, IV pole, doorknobs,
sink, toilet, etc.), other surfaces in patient rooms (i.e., curtains, furniture, thermostats,
soap and paper towel dispensers, trash cans, etc.), equipment in patient rooms (i.e. blood
pressure cuffs, monitors, etc.), equipment traveling between patient rooms (i.e., housekeeping
carts, wheelchairs, etc.), surfaces not in patient rooms (i.e., utility rooms, nurses stations,
etc.), and cleaning equipment (i.e. mops, vacuums, etc.). Each type of surface requires
a different disinfectant depending on vicinity to patients and probable pathogen presence.
Chlorine-derived cleaners are only used when necessary since liquid disinfectants can damage
electronic equipment, corrode metals, harm the environment, and encourage development of
biocide resistant pathogens. Since chlorine-derived cleaners may be harmful to the user,
[36, 79] recommend the use of goggles, gloves, and gowns, when using chlorine-derived
disinfectants. In addition, cleaning, the removal of organic debris using vigorous scrubbing,
must take place before disinfection, the inactivation of pathogens, to ensure that disinfection
is not compromised by protection of pathogen by debris [10]. Disinfecting agents should
remain on surfaces several minutes to ensure disinfection of C. diff spores. Further, each
type of surface has a different cleaning schedule based on vicinity to patients and probable
pathogen presence. High-touch surfaces are typically cleaned daily since they carry heavy
contamination [87], whereas other surfaces not as highly contaminated are only disinfected
upon transfer or discharge. Since cleaning protocols for different parts of hospital rooms vary
widely, it is difficult to decontaminate all surfaces without error. Thus, bacteria accumulates
on surfaces not cleaned as thoroughly or often. A study by [11] evaluated rooms in three
hospitals. They found that sites that were not disinfected upon discharge of a patient tended
to be surfaces not deemed high-touch.
Since C. diff spores can survive for long periods on surfaces not adequately cleaned or
disinfected and have a large presence in healthcare settings correlated with infection rates,
they can be a continuous source of transmission. This raises the question of what kinds
of fomites in a healthcare setting contribute more to the transmission of C. diff infection,
fomites that are interacted with more and tend to be cleaned more often, or fomites that
are interacted with less and tend to be cleaned less often. In this work, fomites are classified
as one of two types: high-touch frequency and low-touch frequency fomites, respectively.
Examples of high-touch frequency fomites include bed rails, tray tables, IV poles, doorknobs,
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sinks, and toilets. Examples of low-touch frequency fomites include curtains, furniture,
thermostats, soap and paper towel dispensers, and trash cans.
2.3 Previous Mathematical Models
2.3.1 Models Incorporating Environmental Pathways
In most epidemiological models of nosocomial infections, transmission is assumed to be
only direct, i.e., through physical contact between susceptible and infected individuals.
Wolkewitz et al. [95], Starr et al. [84], Rubin et al. [78], and Huang et al. [41] formulated
epidemiological models that also included environmental pathways in the transmission of
nosocomial infections.
Vancomycin-resistant enterococci (VRE) is a bacteria that colonizes the intestine, skin,
urinary tract, and open wounds, among other locations, and typically occurs in people
with weakened immune systems. Even though VRE does not form spores like C. diff ,
vegetative cells are capable of cellular respiration in the presence or absence of oxygen and
can thus tolerate a variety of environmental conditions. Wolkewitz et al. [95] formulated
a deterministic ODE model to describe the transmission of VRE among patients in a
healthcare setting including environmental pathways. Patients were classified as uncolonized
or colonized and healthcare workers and surfaces were classified as decontaminated or
contaminated. Patients became colonized via a contact with a contaminated surface or
healthcare worker. Healthcare workers became contaminated via a contact with a colonized
patient or a contaminated surface. Surfaces became contaminated via a contact from a
colonized patient or contaminated healthcare worker. The model tracked the number of
contaminated healthcare workers and surfaces, rather than pathogen level. Cleaning reduced
the number of contaminated surfaces and decontamination, such as hand-washing, reduced
the number of contaminated healthcare workers. The model was used to study the effect of
various intervention strategies that affect colonization, contamination, or decontamination
rates.
Starr et al. [84] formulated a stochastic model to describe the transmission of C. diff
among patients in a healthcare setting including environmental pathways. Patients were
divided into classes based on infection status including immune without antibiotic exposure,
immune with antibiotic exposure, susceptible and uncolonized, susceptible and colonized, and
toxin positive. Individual patients transitioned to different classes at probabilities determined
by class sizes and contact rates. Patients became colonized via contact with a susceptible
and colonized or toxin positive patient, from the same or different hospital room, or from
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the contaminated environment. The contaminated environment was considered independent
of patients’ status and experienced neither contamination growth via patient shedding or
decay via cleaning. The study analyzed the effects of changing parameter values on system
dynamics.
Rubin et al. [78] formulated an agent-based model (ABM) to describe the transmission
of C. diff among patients in a healthcare setting including environmental pathways. ABMs
simulate actions and interactions of individuals with particular characteristics, rather than
classes of individuals, to generate population-level dynamics. Patients were classified as
susceptible, asymptomatically colonized, or symptomatic and occupied individual rooms.
Patients became colonized via occupancy of a room with contaminated surfaces or with
a contaminated healthcare worker. The level of environmental contamination (fraction
of contaminated surfaces) in a room was a function of patient shedding and routine and
terminal cleaning, which proportionally increased or decreased the fraction of contaminated
surfaces. Healthcare workers acquired pathogen (number of spores) if they visited a room
with contaminated surfaces. The model was used to study the effect of various intervention
strategies on system dynamics.
Methicillin-resistant Staphylococcus aureus (MRSA) is a bacteria that is often part
of the normal microbiota in the upper respiratory tract, on skin, and in gut mucosa.
MRSA can cause disease if it takes over the tissues it normally colonizes or invades other
tissues. Even though MRSA does not form spores like C. diff , it can tolerate a variety
of environmental conditions and is often spread through objects used by colonized people.
Huang et al. [41] formulated a deterministic ODE model and a stochastic differential equation
(SDE) model to describe the transmission of MRSA among patients in a healthcare setting
including environmental pathways. Patients were classified as uncolonized without antibiotic
exposure, uncolonized with antibiotic exposure, colonized without antibiotic exposure, and
colonized with antibiotic exposure. Healthcare workers were classified as uncontaminated or
contaminated. Patients became colonized via direct contact with a contaminated healthcare
worker or indirect contact with the contaminated environment. Healthcare workers became
contaminated via direct contact with a colonized patient or indirect contact with the
contaminated environment. The model tracked density of bacteria in aerobic colony counts
per square centimeter, which increased via shedding of colonized patients and contamination
by healthcare workers, and decreased via disinfection. The model was used to explore the
role antibiotic exposure and environmental contamination play in the transmission of MRSA.
47
2.3.2 Lanzas et al. (2011)
Several studies have found evidence to support the hypothesis that asymptomatic patients
are a reservoir for C. diff bacteria. A study by [91] found that environmental contamination
in hospitals continues despite treatment of symptomatic patients, suggesting that asymp-
tomatic patients shed spores into the environment. An analysis by [76] observed that 51%
of long-term care facility residents without C. diff infection were actually asymptomatically
colonized and spores from asymptomatic patients were easily transferred to investigators’
hands. A study by [21] found that 3-18% of healthcare patients may be asymptomatically
colonized with C. diff . The asymptomatic patient reservoir may be significantly contributing
to new infections as well. According to [22], the best diagnostic test for C. diff colonization is
relatively intensive and expensive. Other diagnostic tests that are less intensive or expensive
are not as reliable. Thus, most healthcare facilities only test symptomatic admissions and
patients for C. diff . Therefore, asymptomatic patients shed C. diff spores and contaminate
the environment, but do not prompt implementation of control measures. An investigation
by [18] provided evidence that asymptomatic patients newly admitted to a hospital are an
important source of transmission of C. diff .
Lanzas et al. [50] formulated an epidemiological model of C. diff transmission to evaluate
the relative contributions of asymptomatic and symptomatic patients to new colonizations
within a healthcare setting. The study used data collected from six medicine wards at Barnes-
Jewish Hospital in St. Louis, Missouri during the calendar year 2008 to help parameterize
the model. The data included patient demographics, dates of hospital and ward admission,
dates of discharges and transfers, laboratory tests, and medication exposures. Each ward
contained around 30 beds each. On average, 153 patients were admitted per ward per month
and 2.2 incident cases of symptomatic C. diff infection were reported per ward per month.
In total there were 11,046 patients in the data set with 157 cases of C. diff infection.
Lanzas et al. included the following patient classes in their model: resistant to
colonization (R), susceptible to colonization (S), asymptomatically colonized with protection
against C. diff infection (C+), asymptomatically colonized without protection against C. diff
infection (C−), and diseased (D). A schematic of the model is given in Figure 20. Resistant
individuals (R) have not received antibiotic treatment and therefore have a normal gut
microbiota and are resistant to C. diff colonization. Susceptible individuals (S) have received
antibiotic treatment and therefore do not have a normal gut microbiota and are susceptible
to C. diff colonization. Asymptomatically colonized individuals with protection against C.
diff infection (C+) have C. diff present in the gut, have had an appropriate immune response
to the toxins produced by the bacteria, and do not display symptoms. Asymptomatically
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colonized individuals without protection against C. diff infection (C−) have C. diff present in
the gut, have not had an appropriate immune response to the toxins produced by the bacteria,
and are not displaying symptoms. Diseased individuals (D) are colonized individuals who
are displaying symptoms of C. diff infection. Since diseased individuals (D) receive antibiotic
treatment, they return to the susceptible class (S) if the treatment is successful. Otherwise,
they remain in the diseased class (D). A system of five ODEs deterministically described
the transitions between the patient classes. The system was also simulated stochastically
due to the small population size of the considered hospital ward.
The results of model analysis and simulations demonstrated that the three types of
colonized patients (C+, C−, D) contributed similarly to new colonizations and the proportion
of patients admitted as C− most strongly influenced the number of new cases. The study
emphasized that asymptomatic patients are an important source of transmission of C. diff .
The model in this thesis adds environmental reservoirs to the model formulated by Lanzas
et al. and focuses on the effect of fomite touch frequency on C. diff transmission. Specifically,
this study investigates the contribution of high-touch frequency and low-touch frequency
fomites, both of which can harbor spores shed by symptomatic and asymptomatic patients,
in a hospital ward to new cases of C. diff colonization among hospital patients. Additionally,
this study determines the factors that influence their relative contributions.
2.4 Model Formulation
2.4.1 Description of C. diff Model
This work aims to gain a better understanding of the dynamics of C. diff transmission
through environmental pathways by investigating the contribution of high-touch frequency
and low-touch frequency fomites, both of which can harbor spores shed by symptomatic
and asymptomatic patients, in a hospital ward to new cases of C. diff colonization within
hospital patients. Additionally, this study aims to determine the factors that influence their
relative contributions. In order to address these inquiries, this work develops and analyzes
an epidemiological model that incorporates four classes for the patient population and two
classes for environmental reservoirs of C. diff . Classes are summarized in Table 5 and a
schematic of the model is given in Figure 21.
The four patient classes are similar to the patient classes in Lanzas et al. [50]: resistant
(R), susceptible (S), asymptomatically colonized (C), and diseased (D). Because antibiotic
use is the most significant risk factor for colonization by C. diff , resistant individuals (R)
are defined as individuals that have not received antibiotic treatment. Therefore, they
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have a normal gut microbiota and resistance to C. diff colonization. Likewise, susceptible
individuals (S) are defined as individuals that have received antibiotic treatment. Therefore,
they do not have a normal gut microbiota and are susceptible to C. diff colonization. Since a
patient’s microbiota returns to normal after they have ceased taking antibiotics, susceptible
individuals (S) can return to the resistant class (R). If a susceptible individual (S) is exposed
to C. diff there is a chance they become colonized. Asymptomatically colonized individuals
(C) are defined as individuals that have C. diff present in the gut but are not displaying
symptoms. Diseased individuals (D) are defined as individuals that have C. diff present in
the gut and are displaying symptoms of C. diff infection. Since diseased individuals (D)
receive antibiotic treatment for C. diff infection, they return to the susceptible class (S) if
the treatment is successful. Otherwise, they remain in the diseased class (D). Lanzas et al.
[50] differentiated between colonized individuals with (C+) and without (C−) an appropriate
immune response against C. diff infection. This model does not make this distinction because
the goal of this work is not to evaluate the contribution of asymptomatic patients to the
transmission of C. diff , as was the goal of Lanzas et al. [50]. Instead, this work investigates
the contribution of environmental pathways, to which asymptomatic patients contribute, to
the transmission of C. diff infection. Both types of asymptomatically colonized patients (C+
and C−) shed spores that contribute to the bacterial spore population, and it is assumed
that they both shed spores at the same rate. Instead of differentiating between colonized
individuals with (C+) and without (C−) protection against C. diff infection, the transition
rate from the asymptomatically colonized class (C) to the diseased class (D) incorporates
the fraction of colonized individuals who do not mount a sufficient immune response against
the toxins produced by the bacteria. The remaining asymptomatically colonized individuals
are assumed to have mounted a sufficient immune response and stay in the asymptomatically
colonized class (C) for the duration of their hospital stay. Patients may be admitted into or
discharged from any patient class. Discharge accounts for release from the hospital, transfer
to another ward, or death.
Unlike previous models, this model incorporates two classes for the environmental
reservoirs of C. diff to model the bacteria population as well as the patient population.
The two classes for the environmental reservoirs are: spore density on high-touch frequency
fomites (PH) and spore density on low-touch frequency fomites (PL). High-touch frequency
fomites are interacted with more often by patients and are assumed to be cleaned daily
and disinfected when a patient is discharged. Low-touch frequency fomites are interacted
with less often by patients and are assumed to be disinfected when a patient is discharged.
Examples of high-touch frequency fomites include bed rails, tray tables, IV poles, doorknobs,
sinks, and toilets. Examples of low-touch frequency fomites include curtains, furniture,
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thermostats, soap and paper towel dispensers, and trash cans. Both asymptomatically
colonized (C) and diseased (D) individuals contribute to the level of pathogen on both
types of surfaces. If a susceptible individual (S) is exposed to C. diff there is a chance they
become asymptomatically colonized (C). This depends on which type of surface they have
come in contact with, the spore density on that surface, the chance of transferring C. diff
spores off of the surface, and the chance of becoming colonized from those spores. (This
could also depend on the duration of a contact with a fomite, but is not considered in this
model.)
2.4.2 Parameterization of C. diff Model
Model parameters are described below and summarized in Table 6.
Patient Parameters
The admission proportions for each patient class (aR, aS, aC , aD) are taken from [85],
who used and updated values from Lanzas et al. [50]. Lanzas et al. [50] determined
admission proportions based on collected data from Barnes-Jewish Hospital in St. Louise,
Missouri. In particular, they determined the proportion of patients admitted as susceptible
(aS) was 0.22 and the proportions of patients admitted as asymptomatically colonized with
and without protection were 0.01 each, together making the proportion of patients admitted
as asymptomatically colonized (aC) 0.02. However, [3] suggests that aC is actually as high
as 0.15. In [85], aC was updated from 0.02 to 0.15. aS was subsequently updated from 0.22
to 0.09 since the sum of all of the admission proportions must be 1.
Lanzas et al. [50] determined from their data that a prescription for an antibiotic was
written every two days, on average. Thus, the antibiotic prescription rate (α) is the inverse
of the length between prescriptions, or 0.5 per day. After ceasing antibiotic treatment,
the gut returns to normal after 30 days, on average, according to [73]. Thus, the rate at
which the gut restores its resistance to C. diff colonization (θ) is the inverse of the time
to restoration, or 0.033 per day. For approximately 80% of patients with C. diff infection,
symptoms resolve within a 10 day treatment of vancomycin or metronidazole according to
[63]. Thus, the successful treatment rate (ε) is the product of the proportion of successfully
treated patients and the inverse of the treatment duration, or 0.08 per day. Lanzas et al. [50]
determined from their data that approximately 60% of patients had an appropriate immune
response to the toxins produced by C. diff . According to [16], those that do not mount an
appropriate immune response start to display symptoms after 6 days, on average. Thus, the
disease rate of asymptomatically colonized patients (φ) is the product of the compliment
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of the proportion of patients with an appropriate immune response and the inverse of the
incubation period, or 0.024 per day.
Lanzas et al. [50] determined the average length of stay for patients of each class
from their data. The discharge rate for each patient class (kR, kS, kC , kD) is the inverse
of their average duration in the hospital. The discharge rates for the susceptible and
asymptomatically colonized classes are assumed to be the same (kS = kC = k) because
asymptomatically colonized patients (C) are not tested for C. diff and therefore cannot be
differentiated from susceptible patients (S). Also, asymptomatically colonized patients (C)
are asymptomatic so they do not require additional treatment for C. diff infection and do not
need to remain in the hospital longer than susceptible patients (S) due to C. diff infection.
The total discharge rate (δ(t), derived in Section 2.4.3) is a function of time since it depends
on the size of the patient classes, which are functions of time.
It is assumed that the total ward population is constant at the capacity of the hospital
ward (N = 30), so admission into the hospital ward can only occur if a patient is discharged.
Thus, the admission rates into patient classes are a product of the admission proportions
(aR, aS, aC , aD) and the total discharge rate (δ(t)).
Shedding Parameters
Asymptomatically colonized (C) and diseased (D) patients expel C. diff spores from the body
through bowel movements and diarrhea, respectively. This process is known as bacterial
shedding. Contamination of surfaces occurs when shed spores are deposited on surfaces
through direct contact with soiled hands of patients. Since C. diff spores can survive on
surfaces for long periods of time, it is assumed in the model that natural spore death
is negligible and spores are only killed through cleaning or disinfecting. A study by [17]
observed the number of hand-touch contacts by patients, healthcare workers, and visitors
with any hospital environmental item. Over a period of 66 hours, they observed 12 patients
make 470 contacts, 311 of which were with high-touch frequency fomites and 159 were with
low-touch frequency fomites. Based on this data, patients have 9.424 contacts per day per
individual with high-touch frequency fomites and 4.818 contacts per day per individual with
low-touch frequency fomites. An analysis by [80] cultured stool, skin, and environmental
samples for C. diff from patients with C. diff infection before, during, and after treatment.
They found that a contact with an asymptomatic patient resulted in 3.333 spores on average
and a contact with a symptomatic patient resulted in 7 spores on average on the hand of the
person contacting the patient. With the average surface area of a hand being 0.054 square
meters, according to [44], this results in 0.006 spores per square centimeter per contact
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with an asymptomatically colonized patient (C) and 0.013 spores per square centimeter
per contact with a diseased patient (D). The shedding rates (ρCH , ρCL, ρDH , ρDL) of
asymptomatically colonized (C) or diseased (D) individuals onto high-touch or low-touch
frequency fomites are the product of the contacts per day with a fomite and the spores per
square centimeter per contact from a patient. These calculations are summarized in Table
7.
Cleaning Parameters
The model assumes that both types of fomites are disinfected after a patient is discharged
and only high-touch surfaces are cleaned (not disinfected) daily. However, since this model
is a continuous time model, these are not discrete disinfecting or cleaning events but per
day rates. An analysis by [81] swabbed fomites highly interacted with by patients in nine
acute-care hospitals and two long-term care facilities in four states to determine the typical
microbial burden on high-touch surfaces after daily cleaning and disinfecting upon discharge.
They observed that after daily cleaning, 34% of sites tested contained pathogen and after
disinfecting upon discharge, 17% of sites tested contained pathogen. For this model, the rate
at which C. diff is killed on high-touch surfaces due to daily cleaning (µ) is set to 0.66 per
day, meaning 34% of spores remain on surfaces and 66% of spores are killed per day due to
daily cleaning.
Also, this model does not describe the behavior of individual patients and spores in
individual rooms. It describes average mass action dynamics for homogeneously mixed
classes of patients and classes of surfaces that contain spores. Thus, when considering
disinfection upon discharge, which would only kill spores on surfaces in the discharged
patient’s room, a term is needed to describe the proportion of all spores that are associated
with a single patient and that are killed when disinfected. Therefore, the disinfecting rate
upon discharge is the product of the total discharge rate (δ(t)), the total ward population
(N), and the proportion of spores killed per individual discharged (σ). From [81], the
proportion of spores killed per individual discharge is set to 0.83 per individual, meaning
17% of spores remain on surfaces and 83% of spores are killed after disinfecting upon the
discharge of an individual.
Force of Infection Parameters
The force of infection of an epidemiological model is the rate at which susceptible individuals
contract a disease. In this model the force of infection is the rate at which susceptible
individuals (S) become asymptomatically colonized (C) and is assumed to have a type II
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functional response [37], where the rate of successful colonization increases as pathogen level
in the environment increases and the colonization rate saturates at high levels of pathogen.
Equation (2.1) is an example of a type II functional response where the rate of successful







λ = successful colonization rate
P = pathogen density on contacted fomite
K = half-saturation constant
Figure 22 graphically illustrates the type II functional response in Equation (2.1) for two
different values of the half-saturation constant (K). The half-saturation constant (K) is
the level of pathogen that would make the successful colonization rate half of its maximum
value. Equation (2.1) assumes that if there is a transfer of spores from a contact with a
contaminated fomite, the individual who contacted the contaminated surface will become
colonized. The maximum colonization rate is 1, thus, K would be the pathogen level at
which the rate is 0.5, or at which 50% of susceptibles (S) will become asymptomatically
colonized (C) when they contact a contaminated fomite. In a study by [51], susceptible mice
were held in cages contaminated with C. diff spores isolated from a multi-hospital outbreak.
They found that 5-10 spores per square centimeter in a cage resulted in 50% of the mice
in the cage becoming colonized. This model uses 7.5 spores per square centimeter for the
half-saturation constant (K).
The force of infection in Equation (2.1) is not a realistic representation of the transmission
of C. diff . In reality, an individual may pick up spores off of a surface but not become
colonized. Multiplying the rate at which a contact results in a transfer of spores by the rate
at which a transfer of spores results in a colonization (β) will give a more realistic force of
infection, or successful colonization rate. If a susceptible individual (S) comes into contact
with a high-touch frequency fomite, the successful colonization rate is described by Equation
(2.2). If a susceptible individual (S) comes into contact with a low-touch frequency fomite,











λH = successful colonization rate due to high-touch fomites [day
−1]
λL = successful colonization rate due to low-touch fomites [day
−1]
PH = pathogen density on high-touch fomites [spores · cm−2]
PL = pathogen density on low-touch fomites [spores · cm−2]
K = half-saturation constant [spores · cm−2]
β = colonization rate upon transfer of spores from a fomite [day−1]
ω = weighting constant for high-touch fomites [dimensionless]
A high-touch frequency fomite is defined as a surface that is contacted more often. Thus,
the force of infection, or successful colonization rate due to high-touch fomites has an extra
weighting parameter (ω ≥ 1) to account for the higher frequency of contacts. In the study
[17], patients made 470 contacts with surfaces in a hospital room, 311 of which were with
high-touch frequency fomites and 159 were with low-touch frequency fomites. Therefore,
a patient is 1.96 times more likely to contact a high-touch frequency fomite than a low-
touch frequency fomite. The parameter ω is set to 1.96 to weight the force of infection for
high-touch frequency fomites. Since patients interact with both high-touch and low-touch
frequency fomites, the overall force of infection is the sum of the successful colonization rates













λ = successful colonization rate due to high-touch and low-touch fomites [day−1]
PH = pathogen density on high-touch fomites [spores · cm−2]
PL = pathogen density on low-touch fomites [spores · cm−2]
K = half-saturation constant [spores · cm−2]
β = colonization rate upon transfer of spores from a fomite [day−1]
ω = weighting constant for high-touch fomites [dimensionless]
To estimate the value of β, the force of infection is evaluated at half of the maximum
colonization rate (λmax), when pathogen levels are equal to the half-saturation constant. It
is assumed that λmax = 1. Using PH = PL = K and λ = 0.5 · λmax = 0.5 in Equation (2.4)











=⇒ β = 0.338
where
β = colonization rate upon transfer of spores from a fomite [day−1]
K = half-saturation constant [spores · cm−2]
Thus, 33.8% of contacts with contaminated fomites that resulted in a transfer of spores result
in colonization per day.
2.4.3 C. diff Model
The dynamics of C. diff transmission, including environmental pathways through contact
with high-touch and low-touch frequency fomites, are modeled deterministically using a
six-dimensional system of ODEs describing the mass action transitions between the four
patient classes: resistant individuals (R), susceptible individuals (S), asymptomatically
colonized individuals (C), and diseased individuals (D), and the two environmental reservoir
classes: spore density on high-touch frequency fomites (PH) and spore density on low-touch
frequency fomites (PL). The model is given by the system in Equation (2.6), where
′ denotes
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differentiation with respect to time. Classes are described in Table 5 and parameters are
described in Table 6.
R′ = aRδN − (kR + α)R + θS



















S − (k + φ)C
D′ = aDδN + φC − (kD + ε)D
P ′H = ρCHC + ρDHD − (σδN + µ)PH
P ′L = ρCLC + ρDLD − σδNPL
(2.6)
The total ward population is the sum of the patients in each patient class, given in
Equation (2.7). Taking the derivative of Equation (2.7) with respect to time, plugging in
the expressions for R′, S ′, C ′, and D′ from the system in Equation (2.6), and using the fact
that the sum of the admission proportions must be one (aR + aS + aC + aD = 1) gives the
equation for N ′ in Equation (2.8). It is assumed that the total ward population is constant,
so N ′ = 0. Thus, Equation (2.9) gives the equation for δ(t), the total discharge rate.
N = R + S + C +D (2.7)
=⇒ N ′ = R′ + S ′ + C ′ +D′ (2.8)
= δN − kRR− k(S + C)− kDD
N ′ = 0 =⇒ δ(t) = 1
N
(kRR(t) + k(S(t) + C(t)) + kDD(t)) (2.9)
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where
N = total ward population [individuals]
R = resitant [individuals]
S = susceptible [individuals]
C = asymptomatically colonized [individuals]
D = diseased [individuals]
δ(t) = total discharge rate [day−1]
kR = discharge rate of resistant individuals [day
−1]
k = discharge rate of susceptible and asymptomatically colonized individuals [day−1]
kD = discharge rate of diseased individuals [day
−1]
The discharge rates kR, k, and kD and the total ward population N are constant, and R, S,
C, and D depend on time. Thus, δ(t) must depend on time. Substituting Equation (2.9)
into the system in Equation (2.6) gives the system in Equation (2.10).

R′ = ((aR − 1)kR − α)R + (aRk + θ)S + aRkC + aRkDD
S ′ = (aSkR + α)R +
(









S + aSkC + (aSkD + ε)D











S + ((aC − 1)k − φ)C + aCkDD
D′ = aDkRR + aDkS + (aDk + φ)C + ((aD − 1)kD − ε)D
P ′H = −kRσPHR− kσPHS + (ρCH − kσPH)C + (ρDH − kDσPH)D − µPH
P ′L = −kRσPLR− kσPLS + (ρCL − kσPL)C + (ρDL − kDσPL)D
(2.10)
The solution to Equation (2.10) is simulated by the ODE solver ode45 in MATLAB [62],
a medium order numerical method for nonstiff ODE systems. Figure 23 shows the numerical
solution of the C. diff model described by the system of ODEs in Equation (2.10) for a
total ward population of N = 30. The numerical solution shows the time courses over 40
days of the system variables from Table 5 with reference parameter values from Table 6.
Initial conditions for the patient classes are determined by the admission proportions and
are rounded to the nearest, nonzero integer: S0 = aS · N ≈ 3 individuals, C0 = aC · N ≈ 5
individuals, D0 = daD ·Ne = 1 individuals, R0 = N − S0 − C0 −D0 = 21 individuals. The
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initial conditions for the environmental reservoir classes are PH0 = PL0 = 0.01 spores per
cm2.
2.4.4 Predicted Metrics of C. diff Model
Incidence
For an infectious disease, incidence measures the number of new infections over a period
of time. In this study, the incidence of new diseased cases is calculated as well as the
incidence of new asymptomatically colonized cases, since both patient classes contribute to
the transmission of C. diff in a healthcare setting. However, from the formulation of the
model, only new asymptomatically colonized cases can be linked with the environmental
reservoir class that caused the colonization. Incidence of diseased (ID) is calculated as
the integral over the time period of the rate at which asymptomatically colonized patients
become diseased, or the solution to the ODE in Equation (2.11). Likewise, incidence
of asymptomatically colonized (IC) is calculated as the integral over the time period of
the rate at which susceptible patients become asymptomatically colonized, or the solution
to the ODE in Equation (2.12). Since the rate at which susceptible patients become
asymptomatically colonized depends on the rates attributed to contacts with high-touch
and low-touch frequency fomites (Equations (2.2) and (2.3), respectively), the incidence of
asymptomatically colonized due to a contact with a fomite (ICH and ICL) is calculated as the
integral over the time period of the rate due to a contact with that fomite, or the solutions to
the ODEs in Equations (2.13) and (2.14). For the incidence of asymptomatically colonized,
IC = ICH + ICL.
I ′D = φC (2.11)

























ID = incidence of new diseased [individuals]
IC = incidence of new asymptomatic colonizations [individuals]
ICH = incidence of new asy. colonizations due to high-touch fomites [individuals]
ICL = incidence of new asy. colonizations due to low-touch fomites [individuals]
S = susceptible [individuals]
C = asymptomatically colonized [individuals]
PH = pathogen density on high-touch fomites [spores · cm−2]
PL = pathogen density on low-touch fomites [spores · cm−2]
φ = disease rate [spores · cm−2]
K = half-saturation constant [spores · cm−2]
β = colonization rate upon transfer of spores from a fomite [day−1]
ω = weighting constant for high-touch fomites [dimensionless]
To have perspective on the incidence values, the total number of patients who go through
the hospital ward in the time period is needed. Since the hospital population is assumed to
be constant at the capacity of the ward, admission of a patient can only occur if a patient is
discharged. Thus, the total number of patients will be the total number of patients admitted,
which is the total number of patients discharged, or the integral of the rate at which patients
are discharged. The solution to the ODE in Equation (2.15) gives the total number of
patients.
M ′ = δN = kRR + k(S + C) + kDD (2.15)
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where
M = total number of patients [individuals]
N = total ward population of hospital ward [individuals]
R = resistant [individuals]
S = susceptible [individuals]
C = asymptomatically colonized [individuals]
D = diseased [individuals]
δ(t) = total discharge rate [day−1]
kR = discharge rate of resistant individuals [day
−1]
k = discharge rate of susceptible and asymptomatically colonized individuals [day−1]
kD = discharge rate of diseased individuals [day
−1]
Incidence results for the C. diff model described by the system of ODEs in Equation
(2.10) for a total ward population of N = 30 over 40 days of the system variables from Table
5 with reference parameter values from Table 6 and initial conditions R0 = 21, S0 = 3,
C0 = 5, D0 = 1, and PH0 = PL0 = 0.01 are summarized in Table 10.
Basic Reproduction Number
The basic reproduction number (R0) is defined as the expected number of secondary cases
produced by a single case in a completely susceptible population. This metric conveys the
transmissibility of a pathogen. If R0 < 1 then a few infected individuals introduced to a
completely susceptible population will fail to replace themselves and the epidemic will die
out in the long run. If R0 > 1 then a few infected individuals introduced to a completely
susceptible population will infect others beyond replacing themselves and the epidemic will
spread. Generally, the larger the value of R0, the harder it is to control an epidemic. For
example, R0 is cited to be 1.8 for the 1918 influenza outbreak [6] and is cited to be 12-18
for measles [32]. R0 can be used to calculate important figures like the proportion of the
population that needs to be vaccinated to prevent the spread of a disease.
For this model, the basic reproduction number is the average number of secondary
colonizations produced by a primary C. diff colonization (C or D patient) in a C. diff -
free hospital ward. R0 is based on the linearization of the ODE model about a disease-free
equilibrium. At a disease-free equilibrium, there would be an absence of colonization and
pathogen. Plugging C = D = PH = PL = 0 into Equation (2.10) and setting Equation (2.10)
equal to zero does not give a non-trivial, biologically feasible disease-free equilibrium point.
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In this study, biologically feasible refers to satisfying the constrain N = R + S + C + D.
Without a disease-free equilibrium, there cannot be a scenario in which C. diff infections
are non-existent. As a result, the basic reproduction number cannot be calculated. This
is due to the fact that one of the assumptions needed to have the existence of a disease-
free equilibrium is not met by the model [8]. A criterion for the existence of a disease-free
equilibrium is that all new infections are secondary infections arising from infected hosts and
not due to immigration of individuals into a diseased compartment. Since patients admitted
into the hospital could be asymptomatically colonized or diseased, all new colonizations are
not necessarily secondary colonizations.
2.5 Stochastic Simulations
2.5.1 Gillespie Stochastic Simulation Algorithm
The GSSA [30] was formulated to answer the following question:
If a fixed volume V contains a spatially uniform mixture of N chemical species
which can interact through M specified chemical reaction channels, then given
the numbers of molecules of each species present at some initial time, what will
these molecular population levels be at any later time?
A deterministic model would describe the time course of such a system as a continuous
time, wholly predictable process governed by a set of coupled ODEs called the ‘reaction-rate
equations’. The solution of the system of ODEs would provide the molecular population
levels at a given time. A stochastic model would describe the time course of such a
system as a discrete, random-walk process governed by a single ODE called the ‘master
equation’. The solution of the master equation would give the probability distribution of
the molecular population levels at a given time. The deterministic model would describe
the average behavior of the stochastic model. The stochastic model is more realistic than
the deterministic model since collisions between molecules occur randomly and molecular
population levels change by integer values in discrete time steps. This is especially true
for small molecular population levels, when dynamics may be sensitive to stochasticity.
However, master equations can be difficult to work with and there are no efficient algorithms
to solve them. The GSSA provides a way to make exact numerical calculations within the
framework of the stochastic model without directly solving the master equation. The GSSA
uses a Markov Chain Monte Carlo (MCMC) procedure to sample from the solution of the
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master equation at each time point, creating a trajectory for a possible time course of a
system.
The GSSA views reactions between chemical species as discrete events. Based only on the
current molecular population levels, not past levels, the MCMC procedure determines the
molecular population levels at the next time step by probabilistically determining that time
step and what type of reaction will occur then. For chemical species 1, ..., N and reactions
1, ...,M , the state of the system at time t, given by X(t) = [X1(t), X2(t), ..., XN(t)], is
updated by the following steps of the GSSA:
Step 0. Set the reaction counter as n = 0 and define the initial time as t = 0, the initial
state as X(0), and the reaction probabilities cj for j = {1, ...,M}.
(cjτ is the probability that a particular combination of chemical species will react
via the jth channel in the small time step (t, t+ τ).)
Step 1. Calculate the propensity functions aj and the sum of the propensities a0.
(ajτ is the probability that a reaction will occur via the jth channel in (t, t+ τ)
given the system is in the present state X(t). aj = cjhj where hj is the number
of combinations of chemical species available to react via the jth channel when
the system is in the present state X(t).)
Step 2. Generate two random numbers, r1 and r2, from a uniform distribution on [0, 1].
Calculate the time to the next reaction, τ , and the reaction that occurs next, j.
(The calculations of τ and j are described below.)
Step 3. Set the reaction counter to n = n+ 1 and the next time to t = t+ τ , update the
state to X(t+ τ) based on what reaction occurred, and return to Step 1 unless
a0 = 0 or t+ τ = tfinal.
Calculation of time to next reaction
The occurrence of reactions are assumed to follow a Poisson point process, meaning reactions
occur at known, constant rates and independently of the time since the last reaction. The
probability density function of the Poisson distribution, which describes the probability of a
reaction occurring, is given by Equation (2.16).
P (x|λ) = λ
x
x!
e−λ, x ∈ [0,∞) (2.16)
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where
P = probability of reaction occuring
x = number of times reaction occurs
λ = number of times reaction occurs on average
Equation (2.16) represents the probability of a reaction occurring within a given interval
exactly x times given that the reaction occurs within the given interval λ times on average.
The exponential distribution in Equation (2.17) describes the probability of the time interval
between reactions in a Poisson point process ([19] proves this relationship) and has a mean
of 1/λ.
P (τ |λ) = λe−λτ , τ ∈ [0,∞) (2.17)
where
P = probability of time interval
τ = time interval to next reaction
λ = number of times reaction occurs on average
Equation (2.17) represents the probability of the time interval τ being the interval to the
next reaction given the reaction occurs in the interval λ times on average. The probability
that any of the M reactions will occur in the time interval (t, t + τ), given the system is in
the present state X(t), is the sum of the propensity functions a0 =
∑M
j=1 aj. Thus, the mean
of the Poisson distribution is a0 and the mean of the exponential distribution is 1/a0. The
time to the next reaction (τ) is chosen from the exponential distribution in Equation (2.18).
P (τ |a0) = a0e−a0τ (2.18)
where
P = probability of time interval
τ = time interval to next reaction
a0 = sum of propensity functions
Taking the random number r1, chosen in Step 2 of the Gillespie Algorithm, as P (τ |a0) gives












τ = time interval to next reaction
r1 = random number chosen from uniform distribution on [0, 1]
a0 = sum of propensity functions
Calculation of which reaction occurs
The probability that reaction j = {1, ...,M} is the next reaction is aj/a0. Consider lining up
the probabilities for all j = {1, ...,M} on the number line between 0 and 1. The j for which
the random number r2, from Step 2 of the Gillespie Algorithm, is greater than
∑j−1
k=1 ak/a0
and less than or equal to
∑j
k=1 ak/a0 will be the reaction that occurs next.
2.5.2 Stochastic Simulations of C. diff Model
The ODE model given by the system in Equation (2.10) assumes accuracy based on average
behavior. However, hospital wards have small population sizes, including the considered
ward size of N = 30 in this study. Thus, dynamics can be sensitive to stochasticity,
i.e., a particular outbreak of C. diff in a hospital ward may not necessarily follow the
behavior of an average outbreak. Instead of describing potential time courses of molecular
population levels incorporating the probabilistic occurrence of reactions, in this study
stochastic simulations via the GSSA show particular time courses of the transmission
of C. diff incorporating the probabilistic occurrence of events, or interactions among the
state variables X(t) = [R(t), S(t), C(t), D(t), PH(t), PL(t)]. Examples of events include the
discharge of a patient, the prescription of an antibiotic, and the shedding of spores onto
a fomite. The state variables are involved in 15 different events, summarized in Table 8,
along with the event propensity functions and how the state variables are updated when an
event occurs. The propensity function of an event is the product of the rate at which that
event occurs and the size of the affected state variable at that time. For example, for the
prescription of an antibiotic event, the propensity function is the product of the rate at which
antibiotics are prescribed (α) and the size of the affected state variable (R(t)). When this
event occurs at time t+ τ , one resistant individual becomes susceptible, R(t+ τ) = R(t)− 1
and S(t+ τ) = S(t) + 1, and all other state variables are unchanged.
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Since it is assumed that the total ward population is constant at the capacity of the
hospital ward, admission into the hospital ward can only occur if a patient is discharged.
Thus, a discharge event triggers an admission. When a patient is discharged, the class a new
patient is admitted into is randomly chosen, weighted by the admission proportions. To track
the total number of patients that go through the hospital ward, a counter variable starting at
N = 30, increases by one with each discharge event. Also, when a patient is discharged, both
high-touch and low-touch frequency fomites are disinfected. Thus, as a result of a discharge
event, the spore density on high-touch (PH) and low-touch (PL) frequency fomites is reduced
by the proportion of spores killed when fomites are disinfected due to an individual discharge
(σ).
To track colonization events, or incidence, four counter variables were created in the
algorithm. When a colonization event happens due to a type of fomite, the counter for the
cases due to that type of fomite and the counter for the total number of colonizations increase
by one. When a disease event happens, the counter for the total number of diseased increases
by one. Incidence results are compared to the incidence results of the ODE model and are
summarized in Table 10. When a daily cleaning event occurs, the spore density on high-touch
frequency fomites (PH) is reduced by the proportion of spores killed due to daily cleaning
per individual, µ/N . The daily cleaning event occurs at a rate of once per day and affects all
patient state variables. Thus, the propensity function is N = 1 · (R(t) +S(t) +C(t) +D(t)).
Shedding rates, ρij, i = {C,D}, j = {H,L}, are determined by multiplying the contacts per
day per individual, cpdj, j = {H,L} by the spores per square centimeter transferred per
contact, spci, i = {C,D}. Thus, the propensity function for a shedding event is the contacts
per day per individual, cpdj, j = H,L, multiplied by the number of individuals in the patient
class for the shedding patient (C or D). The pathogen density of the fomite shed on increases
by the spores per square centimeter transferred per contact, spci, i = {C,D}.
Figure 24 shows 100 potential trajectories of the C. diff model generated by the GSSA
with the events in Table 8 for a total ward population of N = 30. The 100 potential
trajectories show possible time courses over 40 days of the system variables from Table 5
with reference parameter values from Table 6. Initial conditions for the patient classes are
determined by the admission proportions and are rounded to the nearest, nonzero integer:
S0 = aS · N ≈ 3 individuals, C0 = aC · N ≈ 5 individuals, D0 = daD · Ne = 1 individuals,
R0 = N − S0 − C0 − D0 = 21 individuals. The initial conditions for the environmental
reservoir classes are PH0 = PL0 = 0.01 spores per cm
2. Figure 25 shows the shaded area that
the middle 95% of the 100 trajectories falls within. Figures 26, 27, and 28 show the ODE
solution compared to the 100 potential trajectories generated by the GSSA and the middle
95% of the trajectories.
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2.6 Results
The model of C. diff transmission including environmental pathways in a hospital ward
is described deterministically by the system of ODEs in Equation (2.10) and simulated
stochastically by the GSSA with events in Table 8 for system variables in Table 5. Five
different scenarios consider a total ward population of N = 30 over 40 days. Parameter values
and initial conditions are varied in each scenario as summarized in Table 9. In all scenarios,
the average behavior of the stochastic simulations generated by the GSSA match the ODE
behavior. Average behavior shows that in all scenarios around three-quarters of the incidence
of asymptomatically colonized is due to a contact with a high-touch frequency fomite and
around one-quarter is due to a contact with a low-touch frequency fomite. This demonstrates
that even with the extra daily cleaning of high-touch frequency fomites, most colonizations
result from the larger frequency of contacts with these surfaces. Individual trajectories
generated by the GSSA show behaviors that the ODE cannot show, and demonstrate that
extreme cases can occur. Two metrics are used to describe the variation in the individual
trajectories: the range of the middle 95% of trajectories at each time point and the variance
in the trajectories at each time point. The range of the middle 95% of trajectories at each
time point is the difference in the 97.5th percentile and the 2.5th percentile at that time.
The mean and maximum of each metric for the asymptomatically colonized and diseased
patient classes are given in Tables 15 and 16. For reference, the data from Lanzas et al. [50]
had 2.2 diseased cases per ward per month, on average, in six wards over 12 months and
11,046 total patients, resulting in an incidence of diseased as 1.43%.
Scenario #0 uses the reference parameter values from Table 6 and initial conditions
described in Section 2.4.3. Figures 23-28, show the time courses and Tables 10, 15, and
16 summarize the results of Scenario #0. The ODE and the average of the 100 trajectories
predict around 7 asymptomatically colonized individuals in approximately 250 total patients
over 40 days. Individual trajectories show that incidence of asymptomatically colonized
ranges from 1 to 15 individuals. Going from 7 to 1 individual is an approximate 86%
decrease and going from 7 to 15 individuals is an approximate 114% increase in the number
of individuals. The average and maximum range of the middle 95% of trajectories is 8.29
and 11, respectively, meaning that at any given time the difference between the number of
asymptomatically colonized individuals between two time courses could be 8.29 individuals
on average, and could be as high as 11 individuals. This does not take into account the 5%
of the most extreme trajectories. Likewise, the ODE and the average of the 100 trajectories
predict around 5-6 diseased individuals in approximately 250 total patients over 40 days.
Individual trajectories show that incidence of diseased ranges from 0 to 7 individuals (not
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shown in Table 10). Going from 5.5 to 0 individuals is a 100% decrease and going from 5.5
to 7 individuals is an approximate 27% increase in the number of individuals. The average
and maximum range of the middle 95% of trajectories is 3.69 and 5, respectively, meaning
that at any given time the difference between the number of diseased individuals between
two time courses could be 3.69 individuals on average, and could be as high as 5 individuals.
Again, this does not take into account the 5% of the most extreme trajectories.
Since the difficulty of quantifying the density of bacteria on surfaces can lead to under-
estimation, Scenario #1 considers an increased initial pathogen level in the environmental
reservoir, i.e., larger initial conditions for the high-touch and low-touch frequency fomites
(PH0 and PL0). Figure 29 and Tables 11, 15, and 16 summarize the results of Scenario #1.
Time courses for Scenario #1 show a slight initial decrease in the environmental reservoir
classes (PH and PL) not seen in the time courses of Scenario #0, but incidence results are
otherwise nearly identical to Scenario #0, except for increased range of the middle 95% of
trajectories and variance in trajectories. The average and maximum range of the middle
95% of trajectories for asymptomatically colonized is 8.86 and 12 individuals, respectively,
and the average and maximum range of the middle 95% of trajectories for diseased is 3.75
and 5 individuals, respectively. It appears that incidence is similar to Scenario #0 because
initially, there are not enough asymptomatically colonized and diseased individuals shedding
onto fomites to counteract cleaning and disinfecting and maintain the higher pathogen levels.
Thus, pathogen levels drop quickly to levels of Scenario #0.
Only symptomatic individuals are tested for C. diff upon admission so the proportion
of individuals that are asymptomatically colonized may be underestimated. Thus, Scenario
#2 considers an increased proportion of individuals admitted as asymptomatically colonized
(aC). Since the sum of all of the admission proportions must be one, aS and aD are decreased.
Figure 30 and Tables 12, 15, and 16 summarize the results of Scenario #2. The ODE and
the average of the 100 trajectories predict around 8 asymptomatically colonized individuals
(7 in Scenario #0) in approximately 250 total patients over 40 days. Individual trajectories
show that incidence of asymptomatically colonized ranges from 2 to 17 individuals (1 to
15 in Scenario #0). The average and maximum range of the middle 95% of trajectories is
9.37 and 12 (8.29 and 11 in Scenario #0), respectively. Mean and maximum variance in
the trajectories of asymptomatically colonized also increased from Scenario #0. Likewise,
the ODE and the average of the 100 trajectories predict around 8 diseased individuals (5-6
in Scenario #0) in approximately 250 total patients over 40 days. Individual trajectories
show that incidence of diseased ranges from 0 to 5 individuals (0 to 7 in Scenario #0
and not shown in Table 12). The average and maximum range of the middle 95% of
trajectories is 3.53 and 4 (3.69 and 5 in Scenario #0), respectively. Mean variance in the
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trajectories of diseased also decreased from Scenario #0. Scenario #2 is the only scenario
in which the incidence of asymptomatically colonized and diseased are almost identical.
In all other scenarios, the incidence of asymptomatically colonized is higher. Scenario
#2 also provides an interesting individual trajectory. The individual trajectory with the
maximum incidence of asymptomatically colonized has over 94% due to a contact with a
high-touch frequency fomite. (Some scenarios have individual trajectories with 100% of
asymptomatically colonized incidence due to high-touch frequency fomites, however, this
occurs in the trajectories with the minimum asymptomatically colonized incidence as 1.)
In an ideal world, every admitted patient would be tested for C. diff and asymptomat-
ically colonized and diseased individuals would be isolated from other patients. Scenario
#3 considers the proportions of asymptomatically colonized and diseased individuals to
be zero. Since the sum of all of the admission proportions must be one, aS is increased.
This case also allows the analysis of the transmission of C. diff in a closed setting without
immigration of outside colonized individuals. Figure 31 and Tables 13, 15, and 16 summarize
the results of Scenario #3. The ODE and the average of the 100 trajectories predict around
1-2 asymptomatically colonized individuals (7 in Scenario #0) in approximately 250 total
patients over 40 days. Individual trajectories show that incidence of asymptomatically
colonized ranges from 0 to 7 individuals (1 to 15 in Scenario #0). The average and
maximum range of the middle 95% of trajectories is 2.39 and 6 (8.29 and 11 in Scenario
#0), respectively. Mean and maximum variance in the trajectories of asymptomatically
colonized also decreased from Scenario #0. Likewise, the ODE and the average of the 100
trajectories predict around 1 diseased individual (5-6 in Scenario #0) in approximately 250
total patients over 40 days. Individual trajectories show that incidence of diseased ranges
from 0 to 4 individuals (0 to 7 in Scenario #0 and not shown in Table 13). The average and
maximum range of the middle 95% of trajectories is 1.47 and 3 (3.69 and 5 in Scenario #0),
respectively. Mean and maximum variance in the trajectories of diseased also decreased
from Scenario #0. Scenario #3 is the only scenario in which the time courses for the
asymptomatically colonized and diseased patient classes and the high-touch and low-touch
frequency fomites environmental reservoir classes go to zero, meaning when pathogen is not
reintroduced through admissions, cleaning and disinfecting is able to eliminate pathogen
from the hospital ward. Scenario #3 also provides an interesting individual trajectory. The
individual trajectory with the minimum incidence of asymptomatically colonized has no new
asymptomatically colonized or diseased individuals, meaning the initial colonized patients
present in the hospital ward recover without infecting other susceptible patients.
Often, compliance with the varied cleaning and disinfecting protocols of hospital surfaces
is suboptimal. Scenario #4 considers reduced efficacy of cleaning and disinfecting, i.e.,
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smaller values for the rate at which spores are killed on high-touch frequency fomites due
to daily cleaning (µ) and the proportion of spores killed when high-touch and low-touch
frequency fomites are disinfected due to a discharge (σ). Figure 32 and Tables 14, 15,
and 16 summarize the results of Scenario #4. The ODE and the average of the 100
trajectories predict around 14-15 asymptomatically colonized individuals (7 in Scenario #0)
in approximately 250 total patients over 40 days. Individual trajectories show that incidence
of asymptomatically colonized ranges from 4 to 31 individuals (1 to 15 in Scenario #0).
The average and maximum range of the middle 95% of trajectories is 9.38 and 12 (8.29
and 11 in Scenario #0), respectively. Mean and maximum variance in the trajectories of
asymptomatically colonized also increased from Scenario #0. Likewise, the ODE and the
average of the 100 trajectories predict around 6 diseased individuals (5-6 in Scenario #0) in
approximately 250 total patients over 40 days. Individual trajectories show that incidence
of diseased ranges from 0 to 6 individuals (0 to 7 in Scenario #0 and not shown in Table
14). The average and maximum range of the middle 95% of trajectories is 3.76 and 5 (3.69
and 5 in Scenario #0), respectively. Mean and maximum variance in the trajectories of
diseased also increased from Scenario #0. Scenario #4 has the largest mean and maximum
range of the middle 95% of trajectories and variance of trajectories of the five scenarios.
Scenario #4 also provides an interesting individual trajectory. The individual trajectory
with the maximum incidence of asymptomatically colonized has over 14% of the 217 total
patients becoming asymptomatically colonized. In the same trajectory, both types of fomites
contributed almost equally to the incidence of asymptomatically colonized.
2.7 Discussion
The difficulty of studying environmental transmission of nosocomial pathogens, a lack of
understanding of these dynamics, and the serious nature of C. diff infections has hindered
the ability to control C. diff infections in healthcare settings. To gain a better understanding
of the dynamics of C. diff transmission, this thesis investigated the contribution of
environmental pathways to C. diff transmission in a healthcare setting by adding the
environmental reservoir classes of high-touch and low-touch frequency fomites to the previous
epidemiological model by Lanzas et al. [50]. Additionally, this study aimed to determine the
factors that influence the relative contributions of the two types of fomites by considering
five scenarios. Due to a small hospital ward size, patient and pathogen populations were
simulated stochastically using the GSSA and compared with the average population behavior
described by a system of ODEs. The treatment of environmental pathways in disease
transmission in this study was novel in the distinction of types of surfaces, including the
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tracking of bacterial spore populations on those surfaces, the distinction between cleaning
and disinfecting of the surfaces, and the associated transmission, shedding, and cleaning
parameters. An abundance of studies dealing with patient-surface contacts and transfer of
pathogen allowed this novelty.
Results show that on average, over three-quarters of asymptomatically colonized patients
are colonized due to a contact with a high-touch frequency fomite and under one-quarter are
colonized due to a contact with a low-touch fomite, despite the extra daily cleaning high-
touch frequency fomites receive. Individual trajectories of the system from the stochastic
simulations showed behaviors and extreme cases not captured by the ODE solution.
Specifically, individual trajectories showed that incidence of asymptomatically colonized
could vary between 1 and 15 individuals, when the average was 7 individuals (2.8% of the
total number of patients), for the reference scenario and could get as high as 31 individuals
(14% of the total number of patients) in another scenario. The stochastic simulations also
showed that in the reference scenario, the number of asymptomatically colonized patients
at any given time could differ by about 8 individuals on average between two different time
courses, not accounting for the 5% of most extreme cases. The scenario with an increase in
the initial pathogen level in the environmental reservoirs, did not differ significantly from the
reference scenario. The scenario with an increased proportion of admitted asymptomatically
colonized patients had higher incidence and larger variability in the trajectories than the
reference scenario. The scenario with no admitted asymptomatically colonized or diseased
patients had lower incidence and lower variability in the trajectories, and saw pathogen
eliminated from the hospital ward. The scenario with reduced efficacy of cleaning and
disinfecting had significantly higher incidence and variability in the trajectories. Forthcoming
sensitivity analysis (by Cara Sulyok) will expectantly provide more insight into the results
of the five scenarios and provide other interesting scenarios to analyze.
The model in this study has a few notable limitations. First, the validity of the model
has not been assessed, i.e., the predictive accuracy of the results have not been compared to
available incidence data.
Second, due to the formulation of the model, fomites were linked to new asymptomatically
colonized cases but not linked to new diseased cases. To be able to keep track of disease
incidence due to a type of fomite, the model would need two asymptomatically colonized
(CH and CL) and two diseased (DH and DL) patient classes. Instead of combining the
successful colonization rates λH and λL in Equations (2.2) and (2.3) to give the successful
colonization rate λ in Equation (2.4) to describe the rate at which susceptibles (S) become
asymptomatically colonized (C), λH would describe the rate at which susceptibles (S)
become asymptomatically colonized due to high-touch frequency fomites (CH) and λL would
71
describe the rate at which susceptibles become asymptomatically colonized due to low-touch
frequency fomites (CL). The rates at which CH patients move to the DH class and CL
patients move to the DL class would be the same: the disease rate φ.
Third, the description of the transmission of C. diff among patients through contacts
with fomites is incomplete. A major contributor to the transmission of C. diff through
environmental pathways is healthcare workers, which are not explicitly considered in this
study. Healthcare workers directly contact patients and fomites, and transfer spores between
them. To include healthcare workers in this model, a class for healthcare workers would
need to be added, as well as a description of how that class interacts with the patient
and environmental reservoir classes, and how colonization of patients occurs through those
interactions. Many of the studies used to calculate parameter values for this model also
contain data on contacts with fomites and transfer of spores for healthcare workers. Thus,
the addition of healthcare workers to this model could be achieved without too much effort.
Visitors of patients should also be considered and could be added to the model in a similar
way as healthcare workers. Also, patients as a source of infection, beyond shedding onto
fomites, was not considered in this study.
The model in this study could be improved upon by considering further classifications
of surfaces beyond high-touch and low-touch frequency fomites. The CDC’s Guidelines for
Environmental Infection Control in Health-Care Facilities [36] and the CDC’s Guideline for
Disinfection and Sterilization in Healthcare Facilities [79] include recommended cleaning
strategies for a variety of fomites. Further, contact time with a fomite would improve the
description of transmission. However, more data would be needed on contacts with and
transfer of spores from these different fomites to be able to calculate parameter values.
In reality patients and surfaces are not homogeneously mixed and interacting at average
rates, as this model describes. Another way to improve upon the model in this study is
to consider describing the same dynamics in an ABM. An ABM would be able to consider
patients and surfaces in individual rooms and track spores on high-touch and low-touch
frequency fomites associated to particular patients.
In future work, this model could be used to analyze the relative effectiveness of disease
control strategies, especially strategies associated with cleaning and disinfecting fomites.
Ultimately, this thesis has demonstrated the need to further study the role of environmental
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A.1 Chapter 1 Tables
Table 1: Variables. Variables for the model formulated to explore physiological control
mechanisms governing HRV. All variables are nonnegative.
Variable Description [Units]
εbc strain of carotid baroreceptors [dimensionless]
εba strain of aortic baroreceptors [dimensionless]
Tbp ∈ (0, Kbp) tone of PSNS due to Baroreflex Mechanism [dimensionless]
Tbs ∈ (0, Kbs) tone of SNS due to Baroreflex Mechanism [dimensionless]
Trp ∈ (0, Krp) tone of PSNS due to RSA [dimensionless]
H ∈ [0, HI(1 +HbsKbs +
HrpKrp)]
heart rate [bpm]
Pas blood pressure of arterial systemic circulation [mmHg]
Pvs blood pressure of venous systemic circulation [mmHg]
Pap blood pressure of arterial pulmonary circulation [mmHg]
Pvp blood pressure of venous pulmonary circulation [mmHg]
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Table 2: Auxiliary Variables. Auxiliary variables for the model formulated to explore
physiological control mechanisms governing HRV. All auxiliary variables are nonnegative.
Variable Description [Units]
Pth thoracic pressure signal [mmHg] (model input)
Pc pressure on carotid baroreceptors [mmHg]
Pa pressure on aortic baroreceptors [mmHg]
εwc ∈ (0, 1) arterial wall strain of carotid sinuses [dimensionless]
εwa ∈ (0, 1) arterial wall strain of aortic arch [dimensionless]
n afferent signal of baroreceptors [sec−1]
Gbp ∈ [Gbpmin , 1]
activation level of PSNS due to Baroreflex Mechanism
[dimensionless]
Gbs ∈ [Gbsmin , 1]
activation level of SNS due to Baroreflex Mechanism
[dimensionless]
Grp ∈ [Grpmin , 1] activation level of PSNS due to RSA [dimensionless]
H̃ ∈ [0, HI(1 +HbsKbs +
HrpKrp)]
weighted intrinsic heart rate [bpm]
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Table 3: Parameters. Parameters for the model formulated to explore physiological
control mechanisms governing HRV with reference values. All variables are nonnegative.
Continued on next three pages.
Parameter Description [Units] Reference Value Source
A > 1
maximally stressed to unstressed
arterial cross-sectional area ratio
[dimensionless]
5 [75]
B ∈ [0, 1]
linear combination constant for




sigmoid steepness constant for
arterial wall strain [dimensionless]
3 —
qbp
sigmoid steepness constant for





sigmoid steepness constant for





sigmoid steepness constant for








sigmoid shift constant for










sigmoid shift constant for











Table 3 Continued: Parameters. Parameters for the model formulated to explore
physiological control mechanisms governing HRV with reference values. All variables are
nonnegative. Continued on next two pages.
Parameter Description [Units] Reference Value Source
srp
sigmoid shift constant for











minimum activation level of PSNS





minimum activation level of SNS





minimum activation level of PSNS
due to RSA [dimensionless]
0 —
Kb < 1




gain constant for tone of PSNS









gain constant for tone of PSNS
due to RSA [dimensionless]
1 [75]
τb




time constant for tone of PSNS
due to Baroreflex Mechanism [sec]
1.8 [75]
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Table 3 Continued: Parameters. Parameters for the model formulated to explore
physiological control mechanisms governing HRV with reference values. All variables are
nonnegative. Continued on page.
Parameter Description [Units] Reference Value Source
τbs
time constant for tone of SNS due
to Baroreflex Mechanism [sec]
10 [75]
τrp
time constant for tone of PSNS
due to RSA [sec]
6 [75]
τH time constant for heart rate [sec] 0.5 [75]
age age of patient [years] patient specific data




weighting constant for tone of




weighting constant for tone of SNS




weighting constant for tone of
PSNS due to RSA [dimensionless]
0.29 —
cas
compliance constant for arterial
systemic circulation [L ·mmHg−1]
0.01016 [57]
cvs
compliance constant for venous
systemic circulation [L ·mmHg−1]
0.65 [57]
cap










Table 3 Continued: Parameters. Parameters for the model formulated to explore
physiological control mechanisms governing HRV with reference values. All variables are
nonnegative.









[L ·mmHg−1 · beat−1]
0.0474 [57]
Rs
resistance to blood flow in
systemic circulation
[mmHg ·min · L−1]
6.5 [57]
Rp
resistance to blood flow in
pulmonary circulation
[mmHg ·min · L−1]
0.5 [57]
Vtot total blood volume [L] 5.058 [57]
90
Table 4: Results. Effect of parameter values on the mean of the model predicted heart
rate and the variance of the RR intervals of the model predicted heart rate for the model
formulated to explore physiological control mechanisms governing HRV given in Equation
(1.77). Reference parameter values are summarized in Table 3, including qw = 3, qbp = qbs =
qrp = 10, Hbp = 0.15, Hbs = Hrp = 0.29, and B = 0.5. The mean of the heart rate data
is 68.384 bpm and the variance of the RR intervals of the heart rate data is 0.00227 bpm2.












qw = 0 83.276 0.00110
qw = 0.1 81.838 0.00110
qw = 10 66.012 0.00067
qbp = 0 87.024 0.00099
qbp = 1 71.909 0.00132
qbp = 25 68.333 0.00086
qbs = 0 113.100 0.00090
qbs = 1 74.780 0.00106
qbs = 25 67.418 0.00100
qrp = 0 69.757 0.00018
qrp = 1 70.123 0.00041
qrp = 25 69.745 0.00116
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Table 4 Continued: Results. Effect of parameter values on the mean of the model
predicted heart rate and the variance of the RR intervals of the model predicted heart rate
for the model formulated to explore physiological control mechanisms governing HRV given
in Equation (1.77). Reference parameter values are summarized in Table 3, including qw = 3,
qbp = qbs = qrp = 10, Hbp = 0.15, Hbs = Hrp = 0.29, and B = 0.5. The mean of the heart







Variance of RR Intervals
of Model Predicted
Heart Rate [bpm2]
Hbp = 0 119.980 0.00044
Hbp = 0.05 98.472 0.00081
Hbp = 0.19 64.494 0.00079
Hbs = 0 59.408 0.00128
Hbs = 0.1 63.882 0.00105
Hbs = 0.4 72.600 0.00114
Hrp = 0 64.947 0.00008
Hrp = 0.1 66.460 0.00013
Hrp = 0.4 72.158 0.00190
B = 0 69.687 0.00084
B = 1 70.030 0.00125
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A.2 Chapter 2 Tables
Table 5: Classes. Patient and environmental reservoir classes for the model of C. diff
transmission including environmental pathways in a hospital ward. The total population




C Asymptomatically Colonized [individuals]
D Diseased [individuals]
PH C. diff spore density on high-touch frequency fomites [spores · cm−2]
PL C. diff spore density on low-touch frequency fomites [spores · cm−2]
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Table 6: Parameters. Parameters for the model of C. diff transmission including


















proportion of admitted individuals who are
diseased [dimensionless]
0.01 [85]
kR discharge rate of resistant individuals [day
−1] 0.33 [50]
k




kD discharge rate of diseased individuals [day
−1] 0.068 [50]








α antibiotic prescription rate [day−1] 0.5 [50]
θ
restoration rate of colonization resistance
[day−1]
0.033 [73]
ε successful treatment rate of infection [day−1] 0.08 [63]
φ
disease rate of asymptomatically colonized




Table 6 Continued: Parameters. Parameters for the model of C. diff transmission






shedding rate of asymptomatically colonized
individuals onto high-touch fomites
[spores · cm−2 · individuals−1 · day−1]
0.057 [17, 44, 80]
ρCL
shedding rate of asymptomatically colonized
individuals onto low-touch fomites
[spores · cm−2 · individuals−1 · day−1]
0.029 [17, 44, 80]
ρDH
shedding rate of diseased individuals onto
high-touch fomites
[spores · cm−2 · individuals−1 · day−1]
0.123 [17, 44, 80]
ρDL
shedding rate of diseased individuals onto
low-touch fomites
[spores · cm−2 · individuals−1 · day−1]
0.063 [17, 44, 80]
σ
proportion of spores killed when high-touch




rate of spores killed on high-touch surfaces
due to daily cleaning [day−1]
0.66 [81]
K half-saturation constant [spores · cm−2] 7.5 [51]
β











Table 7: Shedding Parameters. Calculation of the shedding rate parameters for the
model of C. diff transmission including environmental pathways in a hospital ward. The
shedding rates of asymptomatically colonized or diseased individuals onto high-touch or
low-touch frequency fomites are the product of the spores per square centimeter per contact































spcD = 0.013 cpdL = 4.818 ρDL = 0.063
∗based on patient type
∗∗based on fomite type
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Table 8: GSSA Events. Events, state space updates, and propensity functions for the
GSSA for stochastic simulations of the model of C. diff transmission including environmental
pathways in a hospital ward. The state space is X(t) = [R(t), S(t), C(t), D(t), PH(t), PL(t)].
When event 1, 2, 3, or 4 occurs, the class a new patient is admitted as is determined
randomly, weighted by the admission proportions (aR, aS, aC , aD). Thus, the state space
may be updated in one of four possible ways. Also, a counter for the total number of patients
is updated by 1. This counter starts at the hospital ward size of N = 30. Continued on next
page.





(triggers patient admission and
fomite disinfection)
[0, 0, 0, 0,−σPH ,−σPL]∗,
[−1, 1, 0, 0,−σPH ,−σPL]∗∗,
[−1, 0, 1, 0,−σPH ,−σPL]†,




(triggers patient admission and
fomite disinfection)
[1,−1, 0, 0,−σPH ,−σPL]∗,
[0, 0, 0, 0,−σPH ,−σPL]∗∗,
[0,−1, 1, 0,−σPH ,−σPL]†,





(triggers patient admission and
fomite disinfection)
[1, 0,−1, 0,−σPH ,−σPL]∗,
[0, 1,−1, 0,−σPH ,−σPL]∗∗,
[0, 0, 0, 0,−σPH ,−σPL]†,




(triggers patient admission and
fomite disinfection)
[1, 0, 0,−1,−σPH ,−σPL]∗,
[0, 1, 0,−1,−σPH ,−σPL]∗∗,
[0, 0, 1,−1,−σPH ,−σPL]†,
or [0, 0, 0, 0,−σPH ,−σPL]††
kDD
∗state update if admitted patient is resistant
∗∗state update if admitted patient is susceptible
†state update if admitted patient is asymptomatically colonized
††state update if admitted patient is diseased
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Table 8 Continued: GSSA Events. Events, state space updates, and propensity
functions for the GSSA for stochastic simulations of the model of C. diff transmission
including environmental pathways in a hospital ward. The state space is X(t) =
[R(t), S(t), C(t), D(t), PH(t), PL(t)]. When event 7 or 8 occurs, counters for the number
of new colonized cases due to high-touch or low-touch fomites, respectively, and the total
number of new colonized cases are updated by 1 to calculate incidence. When event 9 occurs,
a counter for the number of new diseased cases is updated by 1 to calculate incidence. These
counters start at 0.
No. Event State Update
Propensity
Function
5 antibiotic prescribed [−1, 1, 0, 0, 0, 0] αR
6 gut restored against colonization [1,−1, 0, 0, 0, 0] θS
7
new colonized case due to
high-touch fomites




new colonized case due to
low-touch fomites
[0,−1, 1, 0, 0, 0] β PH
K+PH
S




[0, 1, 0,−1, 0, 0] εD
11 high-touch surfaces cleaned [0, 0, 0, 0,− µ
N
PH , 0] N
12
asymptomatically colonized
individual sheds on high-touch
fomite
[0, 0, 0, 0, spcC , 0] cpdHC
13
asymptomatically colonized
individual sheds on low-touch
fomite
[0, 0, 0, 0, 0, spcC ] cpdLC
14
diseased individual sheds on
high-touch fomite
[0, 0, 0, 0, spcD, 0] cpdHD
15
diseased individual sheds on
low-touch fomite
[0, 0, 0, 0, 0, spcD] cpdLD
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Table 9: Scenarios. Five scenarios with different parameter values or initial conditions
considered for the model of C. diff transmission including environmental pathways in a
hospital ward.
No. Scenario Description
Changed Parameter Values and
Initial Conditions
0 Reference scenario
Parameters: aR = 0.75, aS = 0.09,
aC = 0.15, aD = 0.01, σ = 0.83,
µ = 0.66 (same as in Table 6)
Initial Conditions: R0 = 21, S0 = 3,
C0 = 5, D0 = 1, PH0 = PL0 = 0.01
1
Increase initial pathogen level in
environmental reservoir
Initial Conditions: PH0 = PL0 = 0.1
2
Increase proportion of admitted
asymptomatically colonized
Parameters: aR = 0.75, aS = 0,
aC = 0.25, aD = 0
3
Decrease proportions of admitted
asymptomatically colonized and
diseased
Parameters: aR = 0.75, aS = 0.25,
aC = 0, aD = 0
4
Decrease efficacy of cleaning and
disinfecting
Parameters: σ = 0.42, µ = 0.33
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Table 10: Results from Scenario #0. Incidence of new diseased and asymptomatically colonized patients for the C. diff
model described by the system of ODEs in Equation (2.10) and the GSSA trajectories described by the events in Table 8 for
a total ward population of N = 30 over 40 days, system variables from Table 5, reference parameter values from Table 6, and











Total Patients (M) [individuals] 249.93 249.41 242 219
Incidence of Diseased [individuals] 5.42 (2.17% of M) 5.83 (2.34% of M) 4 (1.65% of M) 2 (0.91% of M)
Incidence of Asy. Colonized (IC)
[individuals]
7.02 (2.81% of M) 6.99 (2.80% of M) 15 (6.20% of M) 1 (0.46% of M)
Incidence of Asy. Colonized due to
High-Touch Fomites [individuals]
5.40 (2.16% of M ,
76.90% of IC)
5.44 (2.18% of M ,
77.83% of IC)
11 (4.55% of M ,
73.33% of IC)
1 (0.46% of M ,
100% of IC)
Incidence of Asy. Colonized due to
Low-Touch Fomites [individuals]
1.62 (0.65% of M ,
23.10% of IC)
1.55 (0.62% of M ,
22.17% of IC)
4 (1.65% of M ,
26.67% of IC)













Table 11: Results from Scenario #1. Incidence of new diseased and asymptomatically colonized patients for the C. diff
model described by the system of ODEs in Equation (2.10) and the GSSA trajectories described by the events in Table 8 for
a total ward population of N = 30 over 40 days, system variables from Table 5, reference parameter values from Table 6, and











Total Patients (M) [individuals] 249.92 249.58 239 277
Incidence of Diseased [individuals] 5.42 (2.17% of M) 5.72 (2.29% of M) 9 (3.77% of M) 2 (0.72% of M)
Incidence of Asy. Colonized (IC)
[individuals]
7.03 (2.81% of M) 6.97 (2.79% of M) 15 (6.28% of M) 1 (0.36% of M)
Incidence of Asy. Colonized due to
High-Touch Fomites [individuals]
5.40 (2.16% of M ,
76.89% of IC)
5.38 (2.16% of M ,
77.19% of IC)
11 (4.60% of M ,
73.33% of IC)
1 (0.36% of M ,
100% of IC)
Incidence of Asy. Colonized due to
Low-Touch Fomites [individuals]
1.62 (0.65% of M ,
23.11% of IC)
1.59 (0.64% of M ,
22.81% of IC)
4 (1.67% of M ,
26.67% of IC)













Table 12: Results from Scenario #2. Incidence of new diseased and asymptomatically colonized patients for the C. diff
model described by the system of ODEs in Equation (2.10) and the GSSA trajectories described by the events in Table 8 for a
total ward population of N = 30 over 40 days, system variables from Table 5, reference parameter values from Table 6 except











Total Patients (M) [individuals] 248.81 248.30 240 268
Incidence of Diseased [individuals] 8.10 (3.26% of M) 8.11 (3.27% of M) 11 (4.58% of M) 11 (4.10% of M)
Incidence of Asy. Colonized (IC)
[individuals]
7.98 (3.21% of M) 8.11 (3.27% of M) 17 (7.08% of M) 2 (0.75% of M)
Incidence of Asy. Colonized due to
High-Touch Fomites [individuals]
6.13 (2.46% of M ,
76.86% of IC)
6.29 (2.53% of M ,
77.56% of IC)
16 (6.67% of M ,
94.12% of IC)
2 (0.75% of M ,
100% of IC)
Incidence of Asy. Colonized due to
Low-Touch Fomites [individuals]
1.85 (0.74% of M ,
23.14% of IC)
1.82 (0.73% of M ,
22.44% of IC)
1 (0.42% of M ,
5.88% of IC)













Table 13: Results from Scenario #3. Incidence of new diseased and asymptomatically colonized patients for the C. diff
model described by the system of ODEs in Equation (2.10) and the GSSA trajectories described by the events in Table 8 for a
total ward population of N = 30 over 40 days, system variables from Table 5, reference parameter values from Table 6 except











Total Patients (M) [individuals] 255.25 256.25 244 247
Incidence of Diseased [individuals] 0.89 (0.35% of M) 0.83 (0.32% of M) 2 (0.82% of M) 0 (0% of M)
Incidence of Asy. Colonized (IC)
[individuals]
1.53 (0.60% of M) 1.57 (0.61% of M) 7 (2.87% of M) 0 (0% of M)
Incidence of Asy. Colonized due to
High-Touch Fomites [individuals]
1.18 (0.46% of M ,
77.00% of IC)
1.21 (0.47% of M ,
77.07% of IC)
5 (2.05% of M ,
71.43% of IC)
0 (0% of M ,
–% of IC)
Incidence of Asy. Colonized due to
Low-Touch Fomites [individuals]
0.35 (0.14% of M ,
23.00% of IC)
0.36 (0.14% of M ,
22.93% of IC)
2 (0.82% of M ,
28.57% of IC)













Table 14: Results from Scenario #4. Incidence of new diseased and asymptomatically colonized patients for the C. diff
model described by the system of ODEs in Equation (2.10) and the GSSA trajectories described by the events in Table 8 for a
total ward population of N = 30 over 40 days, system variables from Table 5, reference parameter values from Table 6 except











Total Patients (M) [individuals] 249.15 247.70 217 287
Incidence of Diseased [individuals] 6.31 (2.53% of M) 6.12 (2.47% of M) 13 (5.99% of M) 5 (1.74% of M)
Incidence of Asy. Colonized (IC)
[individuals]
14.75 (5.92% of M) 14.21 (5.74% of M) 31 (14.29% of M) 4 (1.39% of M)
Incidence of Asy. Colonized due to
High-Touch Fomites [individuals]
11.33 (4.55% of M ,
76.82% of IC)
10.73 (4.33% of M ,
75.51% of IC)
16 (7.37% of M ,
51.61% of IC)
4 (1.39% of M ,
100% of IC)
Incidence of Asy. Colonized due to
Low-Touch Fomites [individuals]
3.42 (1.37% of M ,
23.18% of IC)
3.48 (1.40% of M ,
24.49% of IC)
15 (6.91% of M ,
48.39% of IC)













Table 15: Ranges of Middle 95% of Trajectories. The mean and maximum ranges
of the middle 95% of the 100 trajectories generated by the GSSA for the asymptomatically
colonized and diseased patient classes for Scenarios #0-#4. The range at each time point is














0 8.29 11 3.69 5
1 8.86 12 3.75 5
2 9.37 12 3.53 4
3 2.39 6 1.47 3
4 9.38 12 3.76 5
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Table 16: Variances of Trajectories. The mean and maximum variances of the 100
trajectories generated by the GSSA for the asymptomatically colonized and diseased patient
















0 4.61 7.08 1.13 1.59
1 5.25 7.49 1.17 1.84
2 5.99 8.72 1.07 1.60
3 0.53 2.12 0.20 0.59
4 6.00 8.56 1.22 2.19
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B Figures
B.1 Chapter 1 Figures
Figure 1: PQRST Wave on ECG. The basic pattern of a heart beat seen on an ECG
signal is made up of three parts: a P wave, a QRS wave complex, and a T wave. The R wave
represents the depolarization of the main mass of the ventricles, when the heart pumps out
most of the blood. The RR interval is the time interval between R waves.
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Figure 2: RR Interval Example #1. There are five heart beats (PQRST patterns) in
six seconds on the ECG signal, resulting in an average heart rate of 50 bpm. The variance
in the RR intervals is 0.0167 square seconds. The heart rate at time 1.28 seconds, at the
end of the first RR interval, is 60/1.28 = 46.875 bpm. The heart rate at time 2.36 seconds,
at the end of the second RR interval, is 60/1.08 = 55.556 bpm. The heart rate at the end of
the remaining RR intervals is similarly calculated, resulting in the heart rate signal of bpm
over time.
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Figure 3: RR Interval Example #2. There are nine heart beats (PQRST patterns) in
six seconds on the ECG signal, resulting in an average heart rate of 90 bpm. The variance
in the RR intervals is 0.0006 square seconds. The heart rate at time 0.67 seconds, at the
end of the first RR interval, is 60/0.67 = 89.552 bpm. The heart rate at time 1.37 seconds,
at the end of the second RR interval, is 60/0.70 = 85.714 bpm. The heart rate at the end of
the remaining RR intervals is similarly calculated, resulting in the heart rate signal of bpm
over time.
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Figure 4: Circulation. De-oxygenated blood travels from the body to the right side of the hear via systemic veins. Next,
de-oxygenated blood travels from the right side of the heart to the lungs, to pick up oxygen, via pulmonary arteries. Then,
oxygenated blood travels from the lungs to the left side of the heart via pulmonary veins. Last, blood travels from the right
side of the heart to the body, to deliver oxygen to tissues, via systemic arteries.
110
Figure 5: Patient Data. ECG, ECG-derived respiration, respiration-derived thoracic pressure, blood pressure, and ECG-
derived heart rate data for one control patient.
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Figure 6: Schematic. Schematic of the model formulated to explore physiological control mechanisms governing HRV. Three
processes are represented: the Baroreflex Mechanism, RSA, and circulation. The input into the model is thoracic pressure data,
derived from ECG-derived respiration data.
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Figure 7: Type III Functional Response. A type III functional response describing
arterial cross-sectional area as a function of blood pressure. Cross-sectional area increase as
blood pressure increases and saturates at low and high pressures. The steepness constant q
describes how quickly cross-sectional area increases with increasing blood pressure.
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Figure 8: Activation Level of PSNS and SNS. A type III functional response describing
activation level of the PSNS and SNS due to the Baroreflex Mechanism as a function of the
afferent signal of baroreceptors (and pressure). The activation level of the PSNS increases
as the afferent signal increases and the activation level of the SNS decreases as the afferent
signal increases. Activation levels saturate at low and high signals.
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Figure 9: Four Compartments of Circulation. Arterial systemic circulation carries oxygenated blood from the left side of
the heart to the body, thus the change in blood volume in the as compartment is the difference between the cardiac output of
the left side of the heart (Ql) and the blood flow in systemic circulation (Fs). Arterial pulmonary circulation carries oxygenated
blood from the right side of the heart to the lungs, thus the change in blood volume in the ap compartment is the difference
between the cardiac output of the right side of the heart (Qr) and the blood flow in pulmonary circulation (Fp). The change
in blood volume in the venous systemic circulation compartment (vs) and the venous pulmonary circulation compartment (vp)
are defined similarly.
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Figure 10: Model Output. Time courses of the variables described in Table 1 for the model formulated to explore
physiological control mechanisms governing HRV given in Equation (1.77) with reference parameter values from Table 3 and
initial conditions described in Section 1.5.2.
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Figure 11: Model Output. Time course of the model predicted heart rate for the model formulated to explore physiological
control mechanisms governing HRV given in Equation (1.77) with reference parameter values from Table 3 and initial conditions
described in Section 1.5.2.
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Figure 12: Model Output for Varied qw. Time course of the model predicted heart rate for the model formulated to
explore physiological control mechanisms governing HRV given in Equation (1.77) for three different values of the parameter
qw. The reference parameter value is qw = 3.
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Figure 13: Model Output for Varied qbp. Time course of the model predicted heart rate for the model formulated to
explore physiological control mechanisms governing HRV given in Equation (1.77) for three different values of the parameter
qbp. The reference parameter value is qbp = 10.
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Figure 14: Model Output for Varied qbs. Time course of the model predicted heart rate for the model formulated to
explore physiological control mechanisms governing HRV given in Equation (1.77) for three different values of the parameter
qbs. The reference parameter value is qbs = 10.
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Figure 15: Model Output for Varied qrp. Time course of the model predicted heart rate for the model formulated to
explore physiological control mechanisms governing HRV given in Equation (1.77) for three different values of the parameter
qrp. The reference parameter value is qrp = 10.
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Figure 16: Model Output for Varied Hbp. Time course of the model predicted heart rate for the model formulated to
explore physiological control mechanisms governing HRV given in Equation (1.77) for three different values of the parameter
Hbp. The reference parameter value is Hbp = 0.15.
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Figure 17: Model Output for Varied Hbs. Time course of the model predicted heart rate for the model formulated to
explore physiological control mechanisms governing HRV given in Equation (1.77) for three different values of the parameter
Hbs. The reference parameter value is Hbs = 0.29.
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Figure 18: Model Output for Varied Hrp. Time course of the model predicted heart rate for the model formulated to
explore physiological control mechanisms governing HRV given in Equation (1.77) for three different values of the parameter
Hrp. The reference parameter value is Hrp = 0.29.
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Figure 19: Model Output for Varied B. Time course of the model predicted heart rate for the model formulated to explore
physiological control mechanisms governing HRV given in Equation (1.77) for two different values of the parameter B. The
reference parameter value is B = 0.5.
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B.2 Chapter 2 Figures
Figure 20: Lanzas et al. Model Schematic. Schematic from Lanzas et al. [50] of the
epidemiological model for C. diff transmission in a hospital ward. Five patient classes are
included: resistant (R), susceptible (S), asymptomatically colonized with protection (C+),
asymptomatically colonized without protection (C−), and diseased (D). Admissions and
discharges for each patient class are not shown.
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Figure 21: Schematic. Schematic of the model of C. diff transmission including
environmental pathways in a hospital ward. Four patient classes are included: resistant (R),
susceptible (S), asymptomatically colonized (C), and diseased (D) and two environmental
reservoir classes are included: high-touch frequency fomites (PH) and low-touch frequency
fomites (PL). Admissions and discharges for each patient class are not shown.
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Figure 22: Type II Functional Response. A type II functional response, describing the
force of infection for the model of C. diff transmission including environmental pathways
in a hospital ward, shows the colonization rate increasing as pathogen level increases.
Colonization rate saturates at high levels of pathogen. The half-saturation constant K
is the level of pathogen that would make the colonization rate half of its maximum value.
For smaller values of K (represented by the black line), this value is reached at a smaller
pathogen level. For larger values of K (represented by the blue line), this value is reached
at a larger pathogen level.
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Figure 23: ODE Solution of Scenario #0. The numerical solution of the C. diff model described by the system of ODEs in
Equation (2.10) for a total ward population of N = 30 shows the time courses over 40 days of the system variables from Table
5 with reference parameter values from Table 6 and initial conditions R0 = 21, S0 = 3, C0 = 5, D0 = 1, PH0 = PL0 = 0.01.
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Figure 24: GSSA Trajectories of Scenario #0. The 100 potential trajectories of the C. diff model generated by the GSSA
with the events in Table 8 for a total ward population of N = 30 shows 100 possible time courses over 40 days of the system
variables from Table 5 with reference parameter values from Table 6 and initial conditions R0 = 21, S0 = 3, C0 = 5, D0 = 1,
PH0 = PL0 = 0.01.
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Figure 25: Middle 95% of GSSA Trajectories of Scenario #0. The middle 95% of 100 potential trajectories of the C.
diff model generated by the GSSA with the events in Table 8 for a total ward population of N = 30 shows 100 possible time
courses over 40 days of the system variables from Table 5 with reference parameter values from Table 6 and initial conditions
R0 = 21, S0 = 3, C0 = 5, D0 = 1, PH0 = PL0 = 0.01. The shaded area shows the difference between the 97.5th percentile and
2.5th percentile at each time point.
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Figure 26: Resistant and Susceptible Time Courses of Scenario #0. The ODE solution of the resistant (R) and
susceptible (S) patient classes is compared to the 100 potential trajectories generated by the GSSA and the middle 95% of the
trajectories. The time courses are for a total ward population of N = 30 over 40 days, with reference parameter values from
Table 6 and initial conditions R0 = 21 and S0 = 3.
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Figure 27: Asymptomatically Colonized and Diseased Time Courses of Scenario #0. The ODE solution of the
asymptomatically colonized (C) and diseased (D) patient classes is compared to the 100 potential trajectories generated by the
GSSA and the middle 95% of the trajectories. The time courses are for a total ward population of N = 30 over 40 days, with
reference parameter values from Table 6 and initial conditions C0 = 5 and D0 = 1.
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Figure 28: High-Touch and Low-Touch Frequency Fomites Time Courses of Scenario #0. The ODE solution of
the high-touch frequency fomites (PH) and low-touch frequency fomites (PL) environmental reservoir classes is compared to the
100 potential trajectories generated by the GSSA and the middle 95% of the trajectories. The time courses are for a total ward
population of N = 30 over 40 days, with reference parameter values from Table 6 and initial conditions PH0 = PL0 = 0.01.
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Figure 29: Middle 95% of GSSA Trajectories of Scenario #1. The middle 95% of 100 potential trajectories of the C.
diff model generated by the GSSA with the events in Table 8 for a total ward population of N = 30 shows 100 possible time
courses over 40 days of the system variables from Table 5 with reference parameter values from Table 6 and initial conditions
R0 = 21, S0 = 3, C0 = 5, D0 = 1, PH0 = PL0 = 0.1. The shaded area shows the difference between the 97.5th percentile and
2.5th percentile at each time point.
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Figure 30: Middle 95% of GSSA Trajectories of Scenario #2. The middle 95% of 100 potential trajectories of the C.
diff model generated by the GSSA with the events in Table 8 for a total ward population of N = 30 shows 100 possible time
courses over 40 days of the system variables from Table 5 with reference parameter values from Table 6 except for aR = 0.75,
aS = 0, aC = 0.25, and aD = 0, and initial conditions R0 = 21, S0 = 3, C0 = 5, D0 = 1, PH0 = PL0 = 0.01. The shaded area
shows the difference between the 97.5th percentile and 2.5th percentile at each time point.
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Figure 31: Middle 95% of GSSA Trajectories of Scenario #3. The middle 95% of 100 potential trajectories of the C.
diff model generated by the GSSA with the events in Table 8 for a total ward population of N = 30 shows 100 possible time
courses over 40 days of the system variables from Table 5 with reference parameter values from Table 6 except for aR = 0.75,
aS = 0.25, aC = 0, and aD = 0, and initial conditions R0 = 21, S0 = 3, C0 = 5, D0 = 1, PH0 = PL0 = 0.01. The shaded area
shows the difference between the 97.5th percentile and 2.5th percentile at each time point.
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Figure 32: Middle 95% of GSSA Trajectories of Scenario #4. The middle 95% of 100 potential trajectories of the C.
diff model generated by the GSSA with the events in Table 8 for a total ward population of N = 30 shows 100 possible time
courses over 40 days of the system variables from Table 5 with reference parameter values from Table 6 except for σ = 0.42 and
µ = 0.33, and initial conditions R0 = 21, S0 = 3, C0 = 5, D0 = 1, PH0 = PL0 = 0.01. The shaded area shows the difference
between the 97.5th percentile and 2.5th percentile at each time point.
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